Laboratory Corp. Of America Holdings. (LH) NEW YORK STOCK EXCHANGE INC.
$212.91 0.38 (0.18%)
Market Cap: $18.83B
As of 06/01/23 02:26 PM EDT. Market open.
Laboratory Corp. Of America Holdings. (LH)
NEW YORK STOCK EXCHANGE INC.
$212.91
0.38 (0.18%)
Market Cap: $18.83B
As of 06/01/23 02:26 PM EDT. Market open.
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, ... read more
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020. read less
COMPANY PROFILE
Sector
Health Care and Social Assistance
Industry
Diagnostic Imaging Centers
CEO
Adam Schechter
Full Time Employees
80,000
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
Sector
Health Care and Social Assistance
Industry
Diagnostic Imaging Centers
CEO
Adam Schechter
Full Time Employees
80,000
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
URL
Address
358 S Main St, North Carolina, Burlington, 27215-5837.
PRICE CHART FOR LABORATORY CORP. OF AMERICA HOLDINGS
From:
To:
NEWS
KEY STATS
Open
$213.26
Previous Close
$212.53
Days Range
$209.04 - $213.90
52 week range
$198.49 - $260
Volume
521,652
Avg. Volume (30 days)
592,791
Market Cap
$18.83B
Dividend Yield
1.35%
P/E
18.82
Shares Outstanding
88,600,000
Open
$213.26
Previous Close
$212.53
Days Range
$209.04 - $213.90
52 week range
$198.49 - $260
Volume
521,652
Avg. Volume (30 days)
592,791
Market Cap
$18.83B
Dividend Yield
1.35%
P/E
18.82
Shares Outstanding
88,600,000
Open in: 
Open in:
INSIDER TRANSACTIONS FOR LABORATORY CORP. OF AMERICA HOLDINGS
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Kirchgraber Paul R | CEO, Covance Drug Development | May 19, 2023 | Option Exercise | $182.51 | 4,300 | 784,793 | 17,246 | May 23, 2023, 08:06 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | May 19, 2023 | Sale | $216.91 | 4,300 | 932,707 | 12,946 | May 23, 2023, 08:06 AM |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | May 18, 2023 | Option Exercise | $130.60 | 1,500 | 195,900 | 8,187 | May 22, 2023, 03:08 PM |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | May 18, 2023 | Sale | $216.77 | 1,500 | 325,155 | 6,687 | May 22, 2023, 03:08 PM |
| Schechter Adam H | President & CEO | Mar 30, 2023 | Option Exercise | $224.70 | 18,646 | 4,189,756 | 46,888 | Apr 03, 2023, 10:14 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Mar 30, 2023 | Option Exercise | $224.70 | 2,886 | 648,484 | 12,946 | Apr 03, 2023, 10:13 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 30, 2023 | Option Exercise | $224.70 | 5,179 | 1,163,721 | 42,176 | Apr 03, 2023, 10:11 AM |
| Caveney Brian J | EVP, President of Diagnostics | Mar 30, 2023 | Option Exercise | $224.70 | 2,990 | 671,853 | 20,186 | Apr 03, 2023, 10:09 AM |
| BERBERIAN LANCE | EVP, CIO & CTO | Mar 30, 2023 | Option Exercise | $224.70 | 1,799 | 404,235 | 22,878 | Apr 03, 2023, 10:07 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Mar 30, 2023 | Option Exercise | $224.70 | 2,866 | 643,990 | 10,584 | Apr 03, 2023, 10:05 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Mar 31, 2023 | Sale | $225.81 | 3,897 | 879,982 | 6,687 | Apr 03, 2023, 10:05 AM |
| Seltz Judith C | EVP, CHRO | Mar 30, 2023 | Option Exercise | $224.70 | 1,164 | 261,551 | 4,182 | Apr 03, 2023, 10:03 AM |
| Summy Amy B. | EVP, Chief Marketing Officer | Mar 30, 2023 | Option Exercise | $224.70 | 1,269 | 285,144 | 3,634 | Apr 03, 2023, 09:56 AM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Mar 30, 2023 | Option Exercise | $224.70 | 1,371 | 308,064 | 7,791 | Apr 03, 2023, 09:50 AM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Mar 30, 2023 | Option Exercise | $224.70 | 526 | 118,192 | 3,432 | Apr 03, 2023, 09:49 AM |
| Summy Amy B. | EVP, Chief Marketing Officer | Mar 02, 2023 | Option Exercise | $239.46 | 374 | 89,558 | 1,669 | Mar 06, 2023, 08:04 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 21, 2023 | Option Exercise | $182.51 | 3,000 | 547,530 | 17,069 | Feb 23, 2023, 09:54 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 21, 2023 | Sale | $250.58 | 8,000 | 2,004,675 | 9,069 | Feb 23, 2023, 09:54 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 14, 2023 | Sale | $247.63 | 309 | 76,518 | 6,687 | Feb 16, 2023, 12:51 PM |
| BELINGARD JEAN-LUC | Director | Feb 13, 2023 | Option Exercise | $248.13 | 75 | 18,610 | 16,929 | Feb 14, 2023, 03:25 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 13, 2023 | Option Exercise | $248.13 | 85 | 21,091 | 20,168 | Feb 14, 2023, 03:01 PM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 13, 2023 | Option Exercise | $248.13 | 124 | 30,768 | 16,413 | Feb 14, 2023, 02:59 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 13, 2023 | Option Exercise | $248.13 | 142 | 35,234 | 14,069 | Feb 14, 2023, 02:57 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 13, 2023 | Option Exercise | $248.13 | 195 | 48,385 | 35,640 | Feb 14, 2023, 02:56 PM |
| Schechter Adam H | President & CEO | Feb 13, 2023 | Option Exercise | $248.13 | 1,170 | 290,312 | 23,181 | Feb 14, 2023, 02:55 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 13, 2023 | Option Exercise | $248.13 | 114 | 28,287 | 6,996 | Feb 14, 2023, 02:54 PM |
| Seltz Judith C | EVP, CHRO | Feb 13, 2023 | Option Exercise | $248.13 | 69 | 17,121 | 1,965 | Feb 14, 2023, 02:52 PM |
| Summy Amy B. | EVP, Chief Marketing Officer | Feb 13, 2023 | Option Exercise | $248.13 | 54 | 13,399 | 703 | Feb 14, 2023, 02:51 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 13, 2023 | Option Exercise | $248.13 | 78 | 19,354 | 5,553 | Feb 14, 2023, 02:50 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 13, 2023 | Option Exercise | $248.13 | 38 | 9,429 | 2,160 | Feb 14, 2023, 02:49 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 07, 2023 | Sale | $243.01 | 219 | 53,219 | 5,341 | Feb 09, 2023, 09:27 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 07, 2023 | Sale | $243.01 | 409 | 99,391 | 6,687 | Feb 09, 2023, 09:04 AM |
| Schechter Adam H | President & CEO | Feb 06, 2023 | Option Exercise | $244.50 | 1,368 | 334,476 | 21,695 | Feb 07, 2023, 02:55 PM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 06, 2023 | Option Exercise | $244.50 | 164 | 40,098 | 16,114 | Feb 07, 2023, 02:54 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 06, 2023 | Option Exercise | $244.50 | 108 | 26,406 | 19,963 | Feb 07, 2023, 02:53 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 06, 2023 | Option Exercise | $244.50 | 261 | 63,815 | 35,112 | Feb 07, 2023, 02:52 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 06, 2023 | Option Exercise | $244.50 | 164 | 40,098 | 13,728 | Feb 07, 2023, 02:51 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 06, 2023 | Option Exercise | $244.50 | 151 | 36,920 | 7,096 | Feb 07, 2023, 02:50 PM |
| Seltz Judith C | EVP, CHRO | Feb 06, 2023 | Option Exercise | $244.50 | 84 | 20,538 | 1,798 | Feb 07, 2023, 02:48 PM |
| Summy Amy B. | EVP, Chief Marketing Officer | Feb 06, 2023 | Option Exercise | $244.50 | 83 | 20,294 | 577 | Feb 07, 2023, 02:47 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 06, 2023 | Option Exercise | $244.50 | 81 | 19,805 | 5,560 | Feb 07, 2023, 02:47 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 06, 2023 | Option Exercise | $244.50 | 52 | 12,714 | 2,088 | Feb 07, 2023, 02:45 PM |
| Seltz Judith C | EVP, CHRO | Feb 02, 2023 | Option Exercise | $254.99 | 77 | 19,634 | 1,602 | Feb 06, 2023, 04:00 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 02, 2023 | Option Exercise | $254.99 | 64 | 16,319 | 5,514 | Feb 06, 2023, 03:56 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 03, 2023 | Sale | $253.90 | 173 | 43,925 | 5,341 | Feb 06, 2023, 03:56 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 02, 2023 | Option Exercise | $254.99 | 41 | 10,455 | 1,990 | Feb 06, 2023, 03:55 PM |
| Summy Amy B. | EVP, Chief Marketing Officer | Feb 02, 2023 | Option Exercise | $254.99 | 77 | 19,634 | 393 | Feb 06, 2023, 03:54 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 02, 2023 | Option Exercise | $254.99 | 119 | 30,344 | 7,011 | Feb 06, 2023, 03:51 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 03, 2023 | Sale | $253.90 | 324 | 82,264 | 6,687 | Feb 06, 2023, 03:51 PM |
| Schechter Adam H | President & CEO | Feb 02, 2023 | Option Exercise | $254.99 | 805 | 205,267 | 19,556 | Feb 06, 2023, 03:49 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 02, 2023 | Option Exercise | $254.99 | 141 | 35,954 | 13,332 | Feb 06, 2023, 03:45 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 02, 2023 | Option Exercise | $254.99 | 206 | 52,528 | 34,403 | Feb 06, 2023, 03:43 PM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 02, 2023 | Option Exercise | $254.99 | 144 | 36,719 | 15,718 | Feb 06, 2023, 03:41 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 02, 2023 | Option Exercise | $254.99 | 102 | 26,009 | 19,697 | Feb 06, 2023, 03:40 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Nov 08, 2022 | Sale | $232.67 | 1,116 | 259,660 | 6,687 | Nov 10, 2022, 08:40 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Nov 07, 2022 | Option Exercise | $233.77 | 894 | 208,990 | 7,803 | Nov 08, 2022, 04:27 PM |
| Caveney Brian J | EVP, President of Diagnostics | Nov 07, 2022 | Option Exercise | $233.77 | 894 | 208,990 | 15,398 | Nov 08, 2022, 04:20 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Nov 01, 2022 | Option Exercise | $222.56 | 5,348 | 1,190,251 | 33,842 | Nov 03, 2022, 05:04 PM |
| Schechter Adam H | President & CEO | Nov 01, 2022 | Option Exercise | $222.56 | 893 | 198,746 | 17,588 | Nov 03, 2022, 05:01 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Nov 01, 2022 | Option Exercise | $222.56 | 892 | 198,524 | 13,030 | Nov 03, 2022, 05:00 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Sep 26, 2022 | Sale | $210.62 | 25,000 | 5,265,581 | 46,531 | Sep 28, 2022, 09:12 AM |
| Caveney Brian J | EVP, President of Diagnostics | Sep 07, 2022 | Buy | $231.20 | 44 | 10,173 | 14,282 | Sep 13, 2022, 11:39 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Aug 03, 2022 | Option Exercise | $147.12 | 32,100 | 4,722,543 | 84,258 | Aug 05, 2022, 09:52 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Aug 03, 2022 | Sale | $253.94 | 32,100 | 8,151,450 | 72,996 | Aug 05, 2022, 09:52 AM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 01, 2022 | Option Exercise | $257.94 | 23 | 5,933 | 1,914 | Aug 03, 2022, 11:54 AM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 01, 2022 | Option Exercise | $146.59 | 767 | 112,435 | 2,654 | Aug 03, 2022, 11:54 AM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 01, 2022 | Sale | $258.40 | 2,576 | 665,634 | 1,897 | Aug 03, 2022, 11:54 AM |
| Caveney Brian J | EVP, President of Diagnostics | Jun 07, 2022 | Buy | $242.19 | 42 | 10,172 | 14,172 | Jun 14, 2022, 08:46 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Mar 29, 2022 | Sale | $277.11 | 2,356 | 652,871 | 6,605 | Mar 31, 2022, 10:24 AM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Mar 29, 2022 | Sale | $277.11 | 2,449 | 678,642 | 5,287 | Mar 31, 2022, 10:20 AM |
| BERBERIAN LANCE | EVP, CIO & CTO | Mar 28, 2022 | Option Exercise | $276.42 | 2,360 | 652,351 | 19,502 | Mar 29, 2022, 12:09 PM |
| Caveney Brian J | EVP, President of Diagnostics | Mar 28, 2022 | Option Exercise | $276.42 | 1,883 | 520,499 | 14,130 | Mar 29, 2022, 12:07 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 28, 2022 | Option Exercise | $276.42 | 6,286 | 1,737,576 | 52,158 | Mar 29, 2022, 12:05 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Mar 28, 2022 | Option Exercise | $276.42 | 1,648 | 455,540 | 11,915 | Mar 29, 2022, 12:04 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Mar 28, 2022 | Option Exercise | $276.42 | 1,885 | 521,052 | 8,961 | Mar 29, 2022, 12:03 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Mar 28, 2022 | Option Exercise | $276.42 | 1,792 | 495,345 | 7,736 | Mar 29, 2022, 12:02 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Mar 28, 2022 | Option Exercise | $276.42 | 915 | 252,924 | 3,696 | Mar 29, 2022, 12:00 PM |
| Williams R Sanders | Director | Mar 25, 2022 | Sale | $272.98 | 572 | 156,145 | 6,431 | Mar 29, 2022, 09:46 AM |
| Summy Amy B. | EVP, Chief Marketing Officer | Mar 10, 2022 | Sale | $262.21 | 249 | 65,290 | 250 | Mar 14, 2022, 04:36 PM |
| NEUPERT PETER M | Director | Feb 16, 2022 | Buy | $263.66 | 3,500 | 922,815 | 10,254 | Feb 18, 2022, 08:46 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 15, 2022 | Sale | $273.98 | 207 | 56,714 | 6,605 | Feb 17, 2022, 03:05 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 15, 2022 | Sale | $273.98 | 207 | 56,714 | 5,287 | Feb 17, 2022, 03:03 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 14, 2022 | Option Exercise | $272.68 | 261 | 71,169 | 1,989 | Feb 15, 2022, 04:51 PM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 14, 2022 | Option Exercise | $272.68 | 778 | 212,145 | 12,466 | Feb 15, 2022, 04:48 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 14, 2022 | Option Exercise | $272.68 | 277 | 75,532 | 44,300 | Feb 15, 2022, 04:43 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 14, 2022 | Option Exercise | $272.68 | 108 | 29,449 | 9,856 | Feb 15, 2022, 04:42 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 14, 2022 | Option Exercise | $272.68 | 799 | 217,871 | 16,657 | Feb 15, 2022, 04:40 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 14, 2022 | Option Exercise | $272.68 | 77 | 20,996 | 6,812 | Feb 15, 2022, 04:38 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 14, 2022 | Option Exercise | $272.68 | 77 | 20,996 | 5,494 | Feb 15, 2022, 04:37 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 04, 2022 | Option Exercise | $277.48 | 109 | 30,245 | 14,643 | Feb 08, 2022, 11:19 AM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 04, 2022 | Option Exercise | $277.48 | 165 | 45,784 | 9,912 | Feb 08, 2022, 11:18 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 04, 2022 | Option Exercise | $277.48 | 286 | 79,359 | 43,637 | Feb 08, 2022, 11:16 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 04, 2022 | Option Exercise | $277.48 | 165 | 45,784 | 9,647 | Feb 08, 2022, 11:13 AM |
| Schechter Adam H | President & CEO | Feb 04, 2022 | Option Exercise | $277.48 | 1,412 | 391,802 | 16,474 | Feb 08, 2022, 11:10 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 04, 2022 | Option Exercise | $277.48 | 152 | 42,177 | 6,809 | Feb 08, 2022, 11:08 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 07, 2022 | Sale | $277.38 | 204 | 56,586 | 6,605 | Feb 08, 2022, 11:08 AM |
| Seltz Judith C | EVP, CHRO | Feb 04, 2022 | Option Exercise | $277.48 | 85 | 23,586 | 1,377 | Feb 08, 2022, 11:06 AM |
| Summy Amy B. | EVP, Chief Marketing Officer | Feb 04, 2022 | Option Exercise | $277.48 | 83 | 23,031 | 499 | Feb 08, 2022, 11:03 AM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 04, 2022 | Option Exercise | $277.48 | 82 | 22,753 | 5,505 | Feb 08, 2022, 11:01 AM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 07, 2022 | Sale | $277.38 | 218 | 60,469 | 5,287 | Feb 08, 2022, 11:01 AM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 04, 2022 | Option Exercise | $277.48 | 53 | 14,706 | 1,183 | Feb 08, 2022, 11:00 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 02, 2022 | Option Exercise | $273.18 | 121 | 33,055 | 6,562 | Feb 04, 2022, 12:15 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 03, 2022 | Sale | $271.81 | 161 | 43,761 | 6,401 | Feb 04, 2022, 12:15 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 02, 2022 | Option Exercise | $273.18 | 64 | 17,484 | 5,459 | Feb 04, 2022, 12:14 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 03, 2022 | Sale | $271.81 | 172 | 46,751 | 5,287 | Feb 04, 2022, 12:14 PM |
| Summy Amy B. | EVP, Chief Marketing Officer | Feb 02, 2022 | Option Exercise | $273.18 | 77 | 21,035 | 315 | Feb 04, 2022, 09:45 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 02, 2022 | Option Exercise | $273.18 | 144 | 39,338 | 9,252 | Feb 04, 2022, 09:44 AM |
| Seltz Judith C | EVP, CHRO | Feb 02, 2022 | Option Exercise | $273.18 | 76 | 20,762 | 1,182 | Feb 04, 2022, 09:43 AM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 02, 2022 | Option Exercise | $273.18 | 41 | 11,200 | 1,086 | Feb 04, 2022, 09:42 AM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 02, 2022 | Option Exercise | $273.18 | 147 | 40,157 | 9,517 | Feb 04, 2022, 09:37 AM |
| Schechter Adam H | President & CEO | Feb 02, 2022 | Option Exercise | $273.18 | 803 | 219,364 | 14,379 | Feb 04, 2022, 09:36 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 02, 2022 | Option Exercise | $273.18 | 236 | 64,470 | 42,953 | Feb 04, 2022, 09:34 AM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 02, 2022 | Option Exercise | $273.18 | 103 | 28,138 | 14,379 | Feb 04, 2022, 09:33 AM |
| BELINGARD JEAN-LUC | Director | Feb 02, 2022 | Option Exercise | $273.18 | 78 | 21,308 | 16,262 | Feb 04, 2022, 09:00 AM |
| Gilliland Dwight Gary | Director | Dec 15, 2021 | Sale | $302.26 | 500 | 151,128 | 6,395 | Dec 17, 2021, 10:36 AM |
| Caveney Brian J | EVP, President of Diagnostics | Nov 05, 2021 | Option Exercise | $274.84 | 899 | 247,081 | 9,182 | Nov 09, 2021, 02:49 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Nov 05, 2021 | Option Exercise | $274.84 | 899 | 247,081 | 6,240 | Nov 09, 2021, 02:46 PM |
| Schechter Adam H | President & CEO | Nov 01, 2021 | Option Exercise | $288.78 | 886 | 255,859 | 12,409 | Nov 03, 2021, 11:51 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Nov 01, 2021 | Option Exercise | $288.78 | 4,034 | 1,164,939 | 42,423 | Nov 03, 2021, 11:49 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Nov 01, 2021 | Option Exercise | $288.78 | 898 | 259,324 | 8,953 | Nov 03, 2021, 11:47 AM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Sep 15, 2021 | Option Exercise | $84.86 | 4,500 | 381,870 | 9,765 | Sep 17, 2021, 12:20 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Sep 15, 2021 | Sale | $296.78 | 4,500 | 1,335,510 | 5,265 | Sep 17, 2021, 12:20 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 02, 2021 | Option Exercise | $297.61 | 15 | 4,464 | 1,011 | Aug 03, 2021, 04:16 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Jun 07, 2021 | Option Exercise | $84.86 | 4,500 | 381,870 | 9,737 | Jun 09, 2021, 02:03 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Jun 07, 2021 | Sale | $266.56 | 4,500 | 1,199,520 | 5,237 | Jun 09, 2021, 02:03 PM |
| BELINGARD JEAN-LUC | Director | May 03, 2021 | Option Exercise | $98.49 | 2,600 | 256,074 | 18,169 | May 05, 2021, 10:48 AM |
| BELINGARD JEAN-LUC | Director | May 03, 2021 | Sale | $269.15 | 2,600 | 699,803 | 15,569 | May 05, 2021, 10:48 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Apr 03, 2021 | Option Exercise | $252.67 | 452 | 114,207 | 10,344 | Apr 06, 2021, 12:18 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Mar 30, 2021 | Sale | $251.88 | 667 | 168,004 | 5,006 | Apr 01, 2021, 08:32 AM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Mar 30, 2021 | Sale | $251.88 | 812 | 204,527 | 5,237 | Apr 01, 2021, 08:32 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 27, 2021 | Option Exercise | $251.58 | 3,595 | 904,430 | 37,433 | Mar 30, 2021, 06:46 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Mar 27, 2021 | Option Exercise | $251.58 | 1,079 | 271,455 | 14,186 | Mar 30, 2021, 06:45 PM |
| Caveney Brian J | EVP, President of Diagnostics | Mar 27, 2021 | Option Exercise | $251.58 | 1,079 | 271,455 | 8,001 | Mar 30, 2021, 06:43 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Mar 27, 2021 | Option Exercise | $251.58 | 790 | 198,748 | 9,786 | Mar 30, 2021, 06:42 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Mar 27, 2021 | Option Exercise | $251.58 | 1,079 | 271,455 | 5,673 | Mar 30, 2021, 06:41 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Mar 27, 2021 | Option Exercise | $251.58 | 687 | 172,835 | 6,049 | Mar 30, 2021, 06:40 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 12, 2021 | Option Exercise | $238.26 | 263 | 62,662 | 1,127 | Feb 19, 2021, 02:17 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 18, 2021 | Option Exercise | $157.09 | 2,166 | 340,251 | 2,660 | Feb 19, 2021, 02:17 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 18, 2021 | Sale | $241.51 | 2,317 | 559,590 | 343 | Feb 19, 2021, 02:17 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 12, 2021 | Option Exercise | $238.26 | 158 | 37,645 | 4,634 | Feb 17, 2021, 04:28 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 16, 2021 | Sale | $236.55 | 208 | 49,202 | 4,531 | Feb 17, 2021, 04:28 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 12, 2021 | Option Exercise | $238.26 | 142 | 33,833 | 4,527 | Feb 17, 2021, 04:27 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 16, 2021 | Sale | $237.06 | 188 | 44,567 | 4,424 | Feb 17, 2021, 04:27 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 12, 2021 | Option Exercise | $238.26 | 180 | 42,887 | 8,472 | Feb 17, 2021, 04:25 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 12, 2021 | Option Exercise | $238.26 | 512 | 121,989 | 32,986 | Feb 17, 2021, 04:23 PM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 12, 2021 | Option Exercise | $238.26 | 854 | 203,474 | 6,667 | Feb 17, 2021, 04:22 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 12, 2021 | Option Exercise | $238.26 | 873 | 208,001 | 12,852 | Feb 17, 2021, 04:21 PM |
| Schechter Adam H | President & CEO | Feb 04, 2021 | Option Exercise | $223.78 | 1,028 | 230,046 | 11,288 | Feb 08, 2021, 03:48 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 04, 2021 | Option Exercise | $223.78 | 53 | 11,860 | 523 | Feb 08, 2021, 03:46 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 04, 2021 | Option Exercise | $223.78 | 83 | 18,574 | 4,328 | Feb 08, 2021, 03:43 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Feb 05, 2021 | Sale | $225.85 | 109 | 24,618 | 4,219 | Feb 08, 2021, 03:43 PM |
| Summy Amy B. | EVP, Chief Marketing Officer | Feb 04, 2021 | Option Exercise | $223.78 | 94 | 21,035 | 172 | Feb 08, 2021, 03:42 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 04, 2021 | Option Exercise | $223.78 | 154 | 34,462 | 4,355 | Feb 08, 2021, 03:40 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 05, 2021 | Sale | $225.85 | 203 | 45,848 | 4,152 | Feb 08, 2021, 03:40 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 04, 2021 | Option Exercise | $223.78 | 187 | 41,847 | 8,071 | Feb 08, 2021, 03:39 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 04, 2021 | Option Exercise | $223.78 | 306 | 68,477 | 31,778 | Feb 08, 2021, 03:36 PM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 04, 2021 | Option Exercise | $223.78 | 190 | 42,518 | 4,651 | Feb 08, 2021, 03:35 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Feb 04, 2021 | Option Exercise | $223.78 | 131 | 29,315 | 10,785 | Feb 08, 2021, 03:34 PM |
| Seltz Judith C | EVP, CHRO | Feb 04, 2021 | Option Exercise | $223.78 | 96 | 21,483 | 915 | Feb 08, 2021, 03:33 PM |
| BELINGARD JEAN-LUC | Director | Feb 04, 2021 | Option Exercise | $223.78 | 99 | 22,154 | 15,569 | Feb 08, 2021, 03:14 PM |
| Williams R Sanders | Director | Jan 26, 2021 | Option Exercise | $98.49 | 1,300 | 128,037 | 5,246 | Jan 28, 2021, 12:11 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Nov 06, 2020 | Sale | $214.59 | 588 | 126,179 | 3,949 | Nov 10, 2020, 10:48 AM |
| Caveney Brian J | EVP, President of Diagnostics | Nov 05, 2020 | Option Exercise | $214.42 | 886 | 189,976 | 4,221 | Nov 09, 2020, 09:21 AM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Nov 05, 2020 | Option Exercise | $214.42 | 835 | 179,041 | 4,537 | Nov 09, 2020, 09:19 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Nov 04, 2020 | Sale | $214.14 | 1,500 | 321,204 | 7,698 | Nov 06, 2020, 09:06 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Nov 02, 2020 | Option Exercise | $207.23 | 4,034 | 835,966 | 31,114 | Nov 04, 2020, 05:47 PM |
| Schechter Adam H | President & CEO | Nov 02, 2020 | Option Exercise | $207.23 | 885 | 183,399 | 8,810 | Nov 04, 2020, 05:43 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Nov 02, 2020 | Option Exercise | $207.23 | 895 | 185,471 | 9,198 | Nov 04, 2020, 05:40 PM |
| Caveney Brian J | EVP, President of Diagnostics | Sep 25, 2020 | Option Exercise | $180.99 | 289 | 52,306 | 3,097 | Sep 29, 2020, 01:42 PM |
| Williams R Sanders | Director | Jul 08, 2020 | Option Exercise | $98.49 | 1,300 | 128,037 | 6,395 | Jul 10, 2020, 04:25 PM |
| Williams R Sanders | Director | Jul 08, 2020 | Sale | $173.12 | 1,300 | 225,056 | 5,095 | Jul 10, 2020, 04:25 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Jul 02, 2020 | Sale | $170.00 | 435 | 73,950 | 4,044 | Jul 07, 2020, 09:38 AM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Jun 24, 2020 | Sale | $160.33 | 872 | 139,808 | 4,915 | Jun 26, 2020, 10:06 AM |
| KING DAVID P | Director | May 05, 2020 | Sale | $160.00 | 31,250 | 5,000,000 | 312,554 | May 07, 2020, 12:05 PM |
| Seltz Judith C | EVP, CHRO | Mar 10, 2020 | Buy | $168.56 | 330 | 55,625 | 580 | May 04, 2020, 10:18 AM |
| Seltz Judith C | EVP, CHRO | Feb 28, 2020 | Buy | $174.94 | 250 | 43,735 | 250 | May 04, 2020, 10:18 AM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Apr 03, 2020 | Option Exercise | $113.31 | 372 | 42,151 | 8,087 | Apr 07, 2020, 04:21 PM |
| KING DAVID P | Director | Mar 30, 2020 | Option Exercise | $131.95 | 24,583 | 3,243,727 | 343,804 | Apr 01, 2020, 02:40 PM |
| van der Vaart Sandra D | EVP, Chief Legal Officer | Mar 30, 2020 | Option Exercise | $131.95 | 1,106 | 145,937 | 5,351 | Apr 01, 2020, 02:39 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 30, 2020 | Option Exercise | $131.95 | 5,787 | 763,595 | 26,124 | Apr 01, 2020, 02:33 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Mar 30, 2020 | Option Exercise | $131.95 | 1,014 | 133,797 | 7,449 | Apr 01, 2020, 02:29 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Mar 30, 2020 | Option Exercise | $131.95 | 1,153 | 152,138 | 3,213 | Apr 01, 2020, 02:28 PM |
| BERBERIAN LANCE | EVP, CIO & CTO | Mar 30, 2020 | Option Exercise | $131.95 | 1,695 | 223,655 | 10,543 | Apr 01, 2020, 02:23 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 21, 2020 | Sale | $189.65 | 297 | 56,326 | 297 | Feb 25, 2020, 12:59 PM |
| BELINGARD JEAN-LUC | Director | Feb 19, 2020 | Option Exercise | $77.19 | 3,100 | 239,289 | 41,161 | Feb 21, 2020, 03:52 PM |
| BELINGARD JEAN-LUC | Director | Feb 19, 2020 | Sale | $189.76 | 26,479 | 5,024,761 | 14,682 | Feb 21, 2020, 03:52 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 12, 2020 | Option Exercise | $187.51 | 512 | 96,005 | 18,966 | Feb 14, 2020, 05:32 PM |
| van der Vaart Sandra D | SVP, Global General Counsel | Feb 12, 2020 | Option Exercise | $187.51 | 158 | 29,627 | 2,944 | Feb 14, 2020, 05:11 PM |
| van der Vaart Sandra D | SVP, Global General Counsel | Feb 13, 2020 | Sale | $188.49 | 208 | 39,206 | 2,839 | Feb 14, 2020, 05:11 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 12, 2020 | Option Exercise | $187.51 | 142 | 26,626 | 674 | Feb 14, 2020, 05:07 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 13, 2020 | Sale | $188.49 | 188 | 35,436 | 589 | Feb 14, 2020, 05:07 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 12, 2020 | Option Exercise | $187.51 | 872 | 163,509 | 8,358 | Feb 14, 2020, 04:11 PM |
| Caveney Brian J | EVP, President of Diagnostics | Feb 12, 2020 | Option Exercise | $187.51 | 866 | 162,384 | 2,326 | Feb 14, 2020, 03:51 PM |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Feb 12, 2020 | Option Exercise | $187.51 | 272 | 51,003 | 594 | Feb 14, 2020, 03:50 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 12, 2020 | Option Exercise | $187.51 | 159 | 29,814 | 5,061 | Feb 14, 2020, 03:48 PM |
| KING DAVID P | Director | Feb 12, 2020 | Option Exercise | $187.51 | 3,280 | 615,033 | 313,392 | Feb 14, 2020, 03:42 PM |
| BELINGARD JEAN-LUC | Director | Feb 12, 2020 | Option Exercise | $187.51 | 123 | 23,064 | 38,061 | Feb 14, 2020, 03:30 PM |
| Williams R Sanders | Director | Feb 13, 2020 | Sale | $188.49 | 1,227 | 231,277 | 5,095 | Feb 14, 2020, 03:08 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 07, 2020 | Option Exercise | $182.33 | 82 | 14,951 | 408 | Feb 11, 2020, 01:47 PM |
| Schroeder Mark S | EVP, President-Diagnostics Lab | Feb 10, 2020 | Sale | $181.99 | 108 | 19,655 | 300 | Feb 11, 2020, 01:47 PM |
| van der Vaart Sandra D | SVP, Global General Counsel | Feb 07, 2020 | Option Exercise | $182.33 | 101 | 18,415 | 2,662 | Feb 11, 2020, 01:45 PM |
| van der Vaart Sandra D | SVP, Global General Counsel | Feb 10, 2020 | Sale | $181.99 | 133 | 24,205 | 2,529 | Feb 11, 2020, 01:45 PM |
| Kirchgraber Paul R | CEO, Covance Drug Development | Feb 07, 2020 | Option Exercise | $182.33 | 103 | 18,780 | 4,641 | Feb 11, 2020, 01:43 PM |
| KING DAVID P | Director | Feb 07, 2020 | Option Exercise | $182.33 | 1,252 | 228,277 | 308,923 | Feb 11, 2020, 01:42 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 07, 2020 | Option Exercise | $182.33 | 295 | 53,787 | 17,758 | Feb 11, 2020, 01:39 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 07, 2020 | Option Exercise | $182.33 | 103 | 18,780 | 6,291 | Feb 11, 2020, 01:38 PM |
| BELINGARD JEAN-LUC | Director | Dec 04, 2019 | Option Exercise | $171.82 | 327 | 56,185 | 36,957 | Dec 06, 2019, 03:07 PM |
| KING DAVID P | President & CEO | Oct 28, 2019 | Sale | $165.40 | 30,177 | 4,991,216 | 328,676 | Oct 30, 2019, 05:25 PM |
| ANDERSON KERRII B | Director | Sep 23, 2019 | Option Exercise | $98.49 | 2,600 | 256,074 | 20,533 | Sep 25, 2019, 01:40 PM |
| ANDERSON KERRII B | Director | Sep 23, 2019 | Sale | $171.85 | 2,600 | 446,810 | 17,933 | Sep 25, 2019, 01:40 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Sep 04, 2019 | Option Exercise | $130.60 | 2,466 | 322,060 | 7,126 | Sep 06, 2019, 09:54 AM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Sep 04, 2019 | Sale | $168.59 | 2,466 | 415,743 | 4,660 | Sep 06, 2019, 09:54 AM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Aug 30, 2019 | Sale | $169.80 | 5,902 | 1,002,171 | 6,097 | Sep 04, 2019, 09:04 AM |
| Williams R Sanders | Director | Aug 05, 2019 | Sale | $162.91 | 500 | 81,455 | 6,886 | Aug 07, 2019, 11:40 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Jul 08, 2019 | Sale | $176.75 | 5,563 | 983,260 | 17,059 | Jul 10, 2019, 09:03 AM |
| van der Vaart Sandra D | SVP, Global General Counsel | Jul 08, 2019 | Sale | $176.75 | 2,328 | 411,474 | 2,328 | Jul 10, 2019, 09:02 AM |
| ANDERSON KERRII B | Director | Jun 20, 2019 | Option Exercise | $77.19 | 3,100 | 239,289 | 22,233 | Jun 21, 2019, 03:26 PM |
| ANDERSON KERRII B | Director | Jun 20, 2019 | Sale | $170.00 | 3,100 | 527,000 | 19,133 | Jun 21, 2019, 03:26 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Jun 07, 2019 | Sale | $167.40 | 10,000 | 1,673,971 | 28,366 | Jun 11, 2019, 06:16 PM |
| Williams R Sanders | Director | May 06, 2019 | Sale | $162.20 | 500 | 81,100 | 7,386 | May 08, 2019, 08:21 AM |
| MITTELSTAEDT ROBERT E JR | Director | May 03, 2019 | Option Exercise | $64.42 | 3,700 | 238,354 | 18,909 | May 07, 2019, 11:00 AM |
| MITTELSTAEDT ROBERT E JR | Director | May 03, 2019 | Sale | $166.30 | 3,700 | 615,310 | 15,209 | May 07, 2019, 11:00 AM |
| Uthgenannt Lisa J | Chief Human Resources Officer | May 02, 2019 | Sale | $164.00 | 4,000 | 656,000 | 4,638 | May 06, 2019, 08:45 AM |
| Ratliff John D | CEO, Covance Drug Development | Apr 03, 2019 | Option Exercise | $156.68 | 1,084 | 169,841 | 16,941 | Apr 05, 2019, 12:01 PM |
| KING DAVID P | President & CEO | Apr 01, 2019 | Option Exercise | $154.79 | 41,311 | 6,394,529 | 297,387 | Apr 03, 2019, 05:30 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Apr 01, 2019 | Option Exercise | $154.79 | 10,013 | 1,549,912 | 32,622 | Apr 03, 2019, 05:29 PM |
| van der Vaart Sandra D | SVP, Global General Counsel | Apr 01, 2019 | Option Exercise | $154.79 | 1,782 | 275,836 | 4,656 | Apr 03, 2019, 05:27 PM |
| Dodson Edward T | Principal Accounting Officer | Apr 01, 2019 | Option Exercise | $154.79 | 1,779 | 275,371 | 13,663 | Apr 03, 2019, 05:24 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Apr 01, 2019 | Option Exercise | $154.79 | 3,236 | 500,900 | 8,638 | Apr 03, 2019, 05:20 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Apr 01, 2019 | Option Exercise | $154.79 | 2,287 | 354,005 | 11,999 | Apr 03, 2019, 05:18 PM |
| BELINGARD JEAN-LUC | Director | Feb 12, 2019 | Option Exercise | $146.59 | 104 | 15,245 | 34,013 | Feb 14, 2019, 05:01 PM |
| BELINGARD JEAN-LUC | Director | Feb 12, 2019 | Option Exercise | $64.42 | 3,700 | 238,354 | 36,779 | Feb 14, 2019, 05:01 PM |
| BELINGARD JEAN-LUC | Director | Feb 12, 2019 | Sale | $146.06 | 3,700 | 540,407 | 33,079 | Feb 14, 2019, 05:01 PM |
| KING DAVID P | President & CEO | Feb 12, 2019 | Option Exercise | $146.59 | 1,571 | 230,293 | 246,281 | Feb 14, 2019, 04:44 PM |
| Williams R Sanders | Director | Feb 13, 2019 | Sale | $147.00 | 1,038 | 152,586 | 7,886 | Feb 14, 2019, 04:18 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 12, 2019 | Option Exercise | $146.59 | 54 | 7,916 | 9,912 | Feb 14, 2019, 04:13 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 12, 2019 | Option Exercise | $146.59 | 64 | 9,382 | 28,823 | Feb 14, 2019, 04:10 PM |
| Ratliff John D | CEO, Covance Drug Development | Feb 12, 2019 | Option Exercise | $146.59 | 654 | 95,870 | 15,601 | Feb 14, 2019, 04:08 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 12, 2019 | Option Exercise | $146.59 | 232 | 34,009 | 20,235 | Feb 14, 2019, 04:05 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 12, 2019 | Option Exercise | $146.59 | 70 | 10,261 | 8,756 | Feb 14, 2019, 04:02 PM |
| Caveney Brian J | SVP, Chief Medical Officer | Feb 12, 2019 | Option Exercise | $146.59 | 82 | 12,020 | 151 | Feb 14, 2019, 03:59 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Feb 12, 2019 | Option Exercise | $146.59 | 103 | 15,099 | 4,489 | Feb 14, 2019, 03:58 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Feb 11, 2019 | Option Exercise | $144.29 | 240 | 34,630 | 4,336 | Feb 13, 2019, 12:22 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 11, 2019 | Option Exercise | $144.29 | 124 | 17,892 | 9,770 | Feb 13, 2019, 12:18 PM |
| KING DAVID P | President & CEO | Feb 11, 2019 | Option Exercise | $144.29 | 2,980 | 429,984 | 244,339 | Feb 13, 2019, 12:11 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 11, 2019 | Option Exercise | $144.29 | 143 | 20,633 | 28,654 | Feb 13, 2019, 12:09 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 11, 2019 | Option Exercise | $144.29 | 1,449 | 209,076 | 19,687 | Feb 13, 2019, 12:05 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 11, 2019 | Option Exercise | $144.29 | 1,037 | 149,629 | 8,593 | Feb 13, 2019, 12:00 PM |
| Ratliff John D | CEO, Covance Drug Development | Feb 11, 2019 | Option Exercise | $144.29 | 1,973 | 284,684 | 14,792 | Feb 13, 2019, 11:55 AM |
| Ratliff John D | CEO, Covance Drug Development | Feb 07, 2019 | Option Exercise | $147.46 | 556 | 81,988 | 10,665 | Feb 11, 2019, 07:59 PM |
| KING DAVID P | President & CEO | Feb 07, 2019 | Option Exercise | $147.46 | 1,254 | 184,915 | 239,775 | Feb 11, 2019, 07:56 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 07, 2019 | Option Exercise | $147.46 | 297 | 43,796 | 16,259 | Feb 11, 2019, 07:53 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 07, 2019 | Option Exercise | $147.46 | 82 | 12,092 | 28,277 | Feb 11, 2019, 07:51 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 07, 2019 | Option Exercise | $147.46 | 68 | 10,027 | 9,444 | Feb 11, 2019, 07:48 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Feb 07, 2019 | Option Exercise | $147.46 | 148 | 21,824 | 3,972 | Feb 11, 2019, 07:46 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 07, 2019 | Option Exercise | $147.46 | 104 | 15,336 | 6,133 | Feb 11, 2019, 07:44 PM |
| Williams R Sanders | Director | Nov 27, 2018 | Sale | $162.14 | 350 | 56,749 | 7,886 | Nov 29, 2018, 10:00 AM |
| ANDERSON KERRII B | Director | Nov 05, 2018 | Option Exercise | $64.42 | 3,700 | 238,354 | 21,795 | Nov 07, 2018, 10:54 AM |
| ANDERSON KERRII B | Director | Nov 05, 2018 | Sale | $163.29 | 3,700 | 604,162 | 18,095 | Nov 07, 2018, 10:54 AM |
| Gary M. Huff | CEO, LabCorp Diagnostics | Sep 04, 2018 | Option Exercise | $169.15 | 69 | 11,671 | 1,850 | Sep 06, 2018, 10:21 AM |
| Dodson Edward T | Principal Accounting Officer | Jun 06, 2018 | Option Exercise | $84.86 | 13,000 | 1,103,180 | 22,113 | Jun 08, 2018, 11:11 AM |
| Dodson Edward T | Principal Accounting Officer | Jun 06, 2018 | Sale | $183.35 | 13,000 | 2,383,563 | 9,113 | Jun 08, 2018, 11:11 AM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Jun 04, 2018 | Sale | $182.10 | 4,500 | 819,450 | 3,755 | Jun 06, 2018, 02:59 PM |
| Gilliland Dwight Gary | Director | May 31, 2018 | Sale | $181.29 | 1,263 | 228,967 | 4,637 | Jun 04, 2018, 04:17 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | May 31, 2018 | Sale | $182.30 | 5,500 | 1,002,672 | 6,255 | Jun 04, 2018, 04:16 PM |
| Gary M. Huff | CEO, LabCorp Diagnostics | May 30, 2018 | Sale | $182.50 | 1,610 | 293,823 | 1,610 | Jun 01, 2018, 08:15 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | May 30, 2018 | Sale | $181.21 | 10,000 | 1,812,067 | 18,843 | Jun 01, 2018, 08:14 AM |
| KING DAVID P | President & CEO | May 23, 2018 | Option Exercise | $84.86 | 49,966 | 4,240,115 | 271,635 | May 25, 2018, 11:15 AM |
| KING DAVID P | President & CEO | May 23, 2018 | Sale | $175.37 | 49,966 | 8,762,352 | 227,069 | May 25, 2018, 11:15 AM |
| KING DAVID P | President & CEO | Apr 23, 2018 | Option Exercise | $84.86 | 49,967 | 4,240,200 | 271,636 | Apr 25, 2018, 04:59 PM |
| KING DAVID P | President & CEO | Apr 23, 2018 | Sale | $166.12 | 49,967 | 8,300,692 | 242,869 | Apr 25, 2018, 04:59 PM |
| Gary M. Huff | CEO, LabCorp Diagnostics | Apr 04, 2018 | Option Exercise | $163.84 | 1,376 | 225,444 | 3,220 | Apr 06, 2018, 09:39 AM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Mar 29, 2018 | Option Exercise | $161.75 | 2,121 | 343,072 | 11,440 | Apr 02, 2018, 11:54 AM |
| Dodson Edward T | Principal Accounting Officer | Mar 29, 2018 | Option Exercise | $161.75 | 1,600 | 258,800 | 9,113 | Apr 02, 2018, 11:53 AM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 29, 2018 | Option Exercise | $161.75 | 2,152 | 348,086 | 28,062 | Apr 02, 2018, 11:51 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 29, 2018 | Option Exercise | $161.75 | 8,850 | 1,431,488 | 25,563 | Apr 02, 2018, 11:50 AM |
| KING DAVID P | President & CEO | Mar 29, 2018 | Option Exercise | $161.75 | 33,015 | 5,340,176 | 221,669 | Apr 02, 2018, 11:48 AM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Mar 29, 2018 | Option Exercise | $161.75 | 2,828 | 457,429 | 8,255 | Apr 02, 2018, 11:47 AM |
| KING DAVID P | President & CEO | Mar 23, 2018 | Option Exercise | $84.86 | 49,967 | 4,240,200 | 231,202 | Mar 27, 2018, 09:03 AM |
| KING DAVID P | President & CEO | Mar 23, 2018 | Sale | $164.75 | 49,967 | 8,232,224 | 229,513 | Mar 27, 2018, 09:03 AM |
| Dodson Edward T | Principal Accounting Officer | Mar 12, 2018 | Option Exercise | $175.61 | 111 | 19,493 | 5,861 | Mar 14, 2018, 04:12 PM |
| KING DAVID P | President & CEO | Mar 12, 2018 | Option Exercise | $175.61 | 2,732 | 479,767 | 181,235 | Mar 14, 2018, 03:47 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 12, 2018 | Option Exercise | $175.61 | 129 | 22,654 | 24,619 | Mar 14, 2018, 03:38 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 12, 2018 | Option Exercise | $175.61 | 732 | 128,547 | 14,726 | Mar 14, 2018, 03:33 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Mar 12, 2018 | Option Exercise | $175.61 | 120 | 21,073 | 8,709 | Mar 14, 2018, 03:30 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Mar 12, 2018 | Option Exercise | $175.61 | 184 | 32,312 | 4,590 | Mar 14, 2018, 03:28 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 12, 2018 | Sale | $167.36 | 8,400 | 1,405,839 | 15,931 | Feb 14, 2018, 02:32 PM |
| Ratliff John D | CEO, Covance Drug Development | Feb 09, 2018 | Option Exercise | $168.08 | 2,132 | 358,347 | 9,398 | Feb 13, 2018, 02:08 PM |
| ANDERSON KERRII B | Director | Feb 09, 2018 | Option Exercise | $75.63 | 3,300 | 249,579 | 21,395 | Feb 13, 2018, 01:58 PM |
| ANDERSON KERRII B | Director | Feb 09, 2018 | Sale | $166.10 | 3,300 | 548,123 | 18,095 | Feb 13, 2018, 01:58 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 09, 2018 | Option Exercise | $168.08 | 1,462 | 245,733 | 22,231 | Feb 13, 2018, 01:55 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 09, 2018 | Option Exercise | $168.08 | 1,048 | 176,148 | 8,429 | Feb 13, 2018, 01:54 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 09, 2018 | Option Exercise | $168.08 | 167 | 28,069 | 5,506 | Feb 13, 2018, 01:51 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 09, 2018 | Option Exercise | $168.08 | 144 | 24,204 | 24,284 | Feb 13, 2018, 01:47 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Feb 09, 2018 | Option Exercise | $168.08 | 203 | 34,120 | 4,237 | Feb 13, 2018, 01:46 PM |
| KING DAVID P | President & CEO | Feb 09, 2018 | Option Exercise | $168.08 | 3,138 | 527,435 | 177,890 | Feb 13, 2018, 01:44 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Feb 07, 2018 | Option Exercise | $169.66 | 129 | 21,886 | 3,837 | Feb 09, 2018, 04:16 PM |
| KING DAVID P | President & CEO | Feb 07, 2018 | Option Exercise | $169.66 | 1,264 | 214,450 | 173,485 | Feb 09, 2018, 04:13 PM |
| Ratliff John D | CEO, Covance Drug Development | Feb 07, 2018 | Option Exercise | $169.66 | 560 | 95,010 | 5,430 | Feb 09, 2018, 04:11 PM |
| Gary M. Huff | CEO, LabCorp Diagnostics | Feb 07, 2018 | Option Exercise | $169.66 | 329 | 55,818 | 1,096 | Feb 09, 2018, 04:09 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 07, 2018 | Option Exercise | $169.66 | 299 | 50,728 | 18,816 | Feb 09, 2018, 04:05 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 07, 2018 | Option Exercise | $169.66 | 82 | 13,912 | 23,908 | Feb 09, 2018, 04:02 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 07, 2018 | Option Exercise | $169.66 | 92 | 15,609 | 5,223 | Feb 09, 2018, 04:01 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 07, 2018 | Option Exercise | $169.66 | 105 | 17,814 | 5,980 | Feb 09, 2018, 03:59 PM |
| Schechter Adam H | Director | Feb 08, 2018 | Sale | $169.29 | 1,263 | 213,813 | 6,034 | Feb 09, 2018, 03:56 PM |
| BELINGARD JEAN-LUC | Director | Feb 07, 2018 | Option Exercise | $169.66 | 127 | 21,547 | 33,079 | Feb 09, 2018, 03:47 PM |
| Gilliland Dwight Gary | Director | Oct 30, 2017 | Sale | $153.52 | 971 | 149,068 | 3,501 | Nov 01, 2017, 10:31 AM |
| Gary M. Huff | CEO, LabCorp Diagnostics | Sep 01, 2017 | Option Exercise | $157.61 | 51 | 8,038 | 349 | Oct 23, 2017, 04:10 PM |
| KING DAVID P | President & CEO | Sep 06, 2017 | Option Exercise | $90.74 | 44,687 | 4,054,898 | 258,753 | Sep 07, 2017, 03:35 PM |
| KING DAVID P | President & CEO | Sep 06, 2017 | Sale | $156.86 | 44,687 | 7,009,789 | 221,566 | Sep 07, 2017, 03:35 PM |
| KING DAVID P | President & CEO | Sep 05, 2017 | Option Exercise | $90.74 | 132,713 | 12,042,377 | 346,779 | Sep 07, 2017, 09:18 AM |
| KING DAVID P | President & CEO | Sep 05, 2017 | Sale | $157.06 | 132,713 | 20,843,373 | 214,066 | Sep 07, 2017, 09:18 AM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Aug 25, 2017 | Option Exercise | $69.12 | 31,500 | 2,177,239 | 55,194 | Aug 29, 2017, 02:26 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Aug 25, 2017 | Sale | $155.22 | 31,500 | 4,889,461 | 23,694 | Aug 29, 2017, 02:26 PM |
| Williams R Sanders | Director | Aug 11, 2017 | Option Exercise | $77.19 | 3,100 | 239,289 | 10,073 | Aug 15, 2017, 03:03 PM |
| Williams R Sanders | Director | Aug 11, 2017 | Sale | $156.88 | 3,100 | 486,338 | 9,873 | Aug 15, 2017, 03:03 PM |
| Dodson Edward T | Principal Accounting Officer | Aug 01, 2017 | Sale | $160.13 | 2,871 | 459,740 | 7,702 | Aug 03, 2017, 04:35 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Aug 01, 2017 | Sale | $160.00 | 5,000 | 800,000 | 3,622 | Aug 03, 2017, 04:29 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Aug 01, 2017 | Sale | $159.46 | 5,968 | 951,669 | 18,122 | Aug 03, 2017, 04:22 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Jun 16, 2017 | Option Exercise | $140.77 | 1,926 | 271,123 | 24,090 | Jun 19, 2017, 02:48 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | May 22, 2017 | Sale | $139.85 | 3,613 | 505,260 | 5,789 | May 24, 2017, 11:25 AM |
| BELINGARD JEAN-LUC | Director | May 09, 2017 | Option Exercise | $77.58 | 992 | 76,959 | 32,935 | May 11, 2017, 08:17 AM |
| BELINGARD JEAN-LUC | Director | May 09, 2017 | Sale | $142.19 | 992 | 141,052 | 31,943 | May 11, 2017, 08:17 AM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Mar 29, 2017 | Option Exercise | $143.19 | 3,142 | 449,903 | 9,402 | Mar 31, 2017, 01:50 PM |
| Dodson Edward T | Principal Accounting Officer | Mar 29, 2017 | Option Exercise | $143.19 | 2,850 | 408,092 | 7,754 | Mar 31, 2017, 01:49 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 29, 2017 | Option Exercise | $143.19 | 3,212 | 459,926 | 23,694 | Mar 31, 2017, 01:48 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 29, 2017 | Option Exercise | $143.19 | 9,753 | 1,396,532 | 21,966 | Mar 31, 2017, 01:47 PM |
| KING DAVID P | President & CEO | Mar 29, 2017 | Option Exercise | $143.19 | 48,596 | 6,958,461 | 198,359 | Mar 31, 2017, 01:45 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Mar 13, 2017 | Option Exercise | $144.24 | 3,654 | 527,053 | 8,803 | Mar 14, 2017, 03:17 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Mar 13, 2017 | Option Exercise | $144.24 | 132 | 19,040 | 5,789 | Mar 14, 2017, 02:52 PM |
| Dodson Edward T | Principal Accounting Officer | Mar 13, 2017 | Option Exercise | $144.24 | 149 | 21,492 | 3,849 | Mar 14, 2017, 02:44 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 13, 2017 | Option Exercise | $144.24 | 153 | 22,069 | 19,136 | Mar 14, 2017, 02:43 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 13, 2017 | Option Exercise | $144.24 | 774 | 111,642 | 11,209 | Mar 14, 2017, 02:41 PM |
| KING DAVID P | President & CEO | Mar 13, 2017 | Option Exercise | $144.24 | 2,890 | 416,854 | 144,755 | Mar 14, 2017, 02:39 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 09, 2017 | Sale | $142.47 | 2,300 | 327,691 | 12,556 | Mar 13, 2017, 09:34 AM |
| MITTELSTAEDT ROBERT E JR | Director | Feb 24, 2017 | Option Exercise | $75.63 | 5,300 | 400,839 | 18,208 | Feb 27, 2017, 02:40 PM |
| MITTELSTAEDT ROBERT E JR | Director | Feb 24, 2017 | Sale | $142.69 | 5,300 | 756,256 | 18,008 | Feb 27, 2017, 02:40 PM |
| ANDERSON KERRII B | Director | Feb 23, 2017 | Option Exercise | $76.60 | 1,992 | 152,589 | 16,832 | Feb 27, 2017, 02:39 PM |
| ANDERSON KERRII B | Director | Feb 24, 2017 | Option Exercise | $75.63 | 1,000 | 75,630 | 16,832 | Feb 27, 2017, 02:39 PM |
| ANDERSON KERRII B | Director | Feb 23, 2017 | Sale | $140.00 | 1,992 | 278,880 | 15,832 | Feb 27, 2017, 02:39 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 13, 2017 | Option Exercise | $134.93 | 182 | 24,557 | 3,598 | Feb 14, 2017, 05:45 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 13, 2017 | Option Exercise | $134.93 | 206 | 27,796 | 18,826 | Feb 14, 2017, 05:45 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 13, 2017 | Option Exercise | $134.93 | 552 | 74,481 | 12,656 | Feb 14, 2017, 05:42 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 13, 2017 | Option Exercise | $134.93 | 489 | 65,981 | 5,703 | Feb 14, 2017, 05:42 PM |
| KING DAVID P | President & CEO | Feb 13, 2017 | Option Exercise | $134.93 | 3,968 | 535,402 | 141,568 | Feb 14, 2017, 05:42 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 13, 2017 | Option Exercise | $134.93 | 489 | 65,981 | 5,703 | Feb 14, 2017, 05:40 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Feb 09, 2017 | Option Exercise | $133.83 | 244 | 32,655 | 4,039 | Feb 13, 2017, 02:40 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 09, 2017 | Option Exercise | $133.83 | 138 | 18,469 | 3,230 | Feb 13, 2017, 02:31 PM |
| Ratliff John D | CEO, Covance Drug Development | Feb 09, 2017 | Option Exercise | $133.83 | 2,013 | 269,400 | 4,127 | Feb 13, 2017, 02:28 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 09, 2017 | Option Exercise | $133.83 | 188 | 25,160 | 18,398 | Feb 13, 2017, 02:26 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 09, 2017 | Option Exercise | $133.83 | 1,610 | 215,466 | 11,534 | Feb 13, 2017, 02:24 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 09, 2017 | Option Exercise | $133.83 | 1,171 | 156,715 | 4,530 | Feb 13, 2017, 02:23 PM |
| KING DAVID P | President & CEO | Feb 09, 2017 | Option Exercise | $133.83 | 2,496 | 334,040 | 137,192 | Feb 13, 2017, 02:21 PM |
| BELINGARD JEAN-LUC | Director | Feb 09, 2017 | Option Exercise | $133.83 | 156 | 20,877 | 31,943 | Feb 13, 2017, 01:53 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Aug 09, 2016 | Sale | $140.00 | 1,177 | 164,780 | 3,660 | Aug 11, 2016, 07:57 AM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Aug 04, 2016 | Sale | $140.10 | 8,000 | 1,120,804 | 8,668 | Aug 08, 2016, 02:58 PM |
| MITTELSTAEDT ROBERT E JR | Director | Aug 04, 2016 | Option Exercise | $77.58 | 992 | 76,959 | 12,340 | Aug 08, 2016, 02:55 PM |
| MITTELSTAEDT ROBERT E JR | Director | Aug 04, 2016 | Sale | $140.15 | 992 | 139,027 | 11,348 | Aug 08, 2016, 02:55 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Jun 16, 2016 | Option Exercise | $127.35 | 1,936 | 246,550 | 16,268 | Jun 20, 2016, 10:38 AM |
| KING DAVID P | President & CEO | Jun 13, 2016 | Option Exercise | $70.15 | 196,400 | 13,777,460 | 271,210 | Jun 15, 2016, 04:03 PM |
| KING DAVID P | President & CEO | Jun 13, 2016 | Sale | $128.00 | 196,400 | 25,139,088 | 197,755 | Jun 15, 2016, 04:03 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Apr 29, 2016 | Sale | $125.17 | 3,740 | 468,136 | 4,837 | May 13, 2016, 04:03 PM |
| Dodson Edward T | Principal Accounting Officer | Apr 27, 2016 | Sale | $126.42 | 9,392 | 1,187,337 | 2,717 | Apr 29, 2016, 09:01 AM |
| KING DAVID P | President & CEO | Mar 30, 2016 | Option Exercise | $117.85 | 48,425 | 5,706,886 | 147,371 | Apr 01, 2016, 01:22 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 30, 2016 | Option Exercise | $117.85 | 6,007 | 707,925 | 14,154 | Apr 01, 2016, 01:21 PM |
| Dodson Edward T | Principal Accounting Officer | Mar 30, 2016 | Option Exercise | $117.85 | 2,349 | 276,830 | 12,109 | Apr 01, 2016, 01:15 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 30, 2016 | Option Exercise | $117.85 | 2,466 | 290,618 | 22,285 | Apr 01, 2016, 01:12 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 31, 2016 | Sale | $116.85 | 4,219 | 492,990 | 18,066 | Apr 01, 2016, 01:12 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Mar 30, 2016 | Option Exercise | $117.85 | 16,605 | 1,956,899 | 41,586 | Apr 01, 2016, 01:11 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Mar 31, 2016 | Sale | $116.81 | 18,132 | 2,118,030 | 28,395 | Apr 01, 2016, 01:11 PM |
| BELINGARD JEAN-LUC | Director | Mar 11, 2016 | Option Exercise | $115.49 | 124 | 14,321 | 30,539 | Mar 15, 2016, 03:35 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Mar 11, 2016 | Option Exercise | $115.49 | 133 | 15,360 | 2,205 | Mar 15, 2016, 01:45 PM |
| Dodson Edward T | Principal Accounting Officer | Mar 11, 2016 | Option Exercise | $115.49 | 124 | 14,321 | 7,773 | Mar 15, 2016, 01:44 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Mar 11, 2016 | Option Exercise | $115.49 | 778 | 89,851 | 7,596 | Mar 15, 2016, 01:42 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 11, 2016 | Option Exercise | $115.49 | 154 | 17,785 | 18,375 | Mar 15, 2016, 01:41 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 14, 2016 | Sale | $115.32 | 309 | 35,634 | 18,066 | Mar 15, 2016, 01:41 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Mar 11, 2016 | Option Exercise | $115.49 | 1,413 | 163,187 | 24,997 | Mar 15, 2016, 01:39 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Mar 14, 2016 | Sale | $115.32 | 1,543 | 177,939 | 23,454 | Mar 15, 2016, 01:39 PM |
| KING DAVID P | President & CEO | Mar 11, 2016 | Option Exercise | $115.49 | 2,905 | 335,498 | 94,489 | Mar 15, 2016, 01:37 PM |
| Keller Deborah L | CEO, Covance Drug Development | Mar 11, 2016 | Option Exercise | $115.49 | 4,587 | 529,753 | 19,754 | Mar 15, 2016, 01:36 PM |
| Uthgenannt Lisa J | Chief Human Resources Officer | Mar 11, 2016 | Option Exercise | $115.49 | 3,379 | 390,241 | 8,577 | Mar 15, 2016, 01:34 PM |
| BELINGARD JEAN-LUC | Director | Feb 25, 2016 | Option Exercise | $59.37 | 1,296 | 76,944 | 30,722 | Feb 29, 2016, 01:52 PM |
| BELINGARD JEAN-LUC | Director | Feb 25, 2016 | Sale | $109.74 | 1,296 | 142,225 | 30,504 | Feb 29, 2016, 01:52 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Feb 16, 2016 | Sale | $103.02 | 4,055 | 417,746 | 25,614 | Feb 18, 2016, 08:28 AM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 16, 2016 | Sale | $103.02 | 370 | 38,117 | 18,066 | Feb 18, 2016, 08:27 AM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Feb 12, 2016 | Option Exercise | $103.02 | 2,116 | 217,990 | 27,509 | Feb 16, 2016, 04:30 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Feb 11, 2016 | Option Exercise | $101.40 | 1,345 | 136,383 | 26,166 | Feb 16, 2016, 04:30 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Feb 12, 2016 | Sale | $101.67 | 2,712 | 275,729 | 23,454 | Feb 16, 2016, 04:30 PM |
| KING DAVID P | President & CEO | Feb 11, 2016 | Option Exercise | $101.40 | 2,768 | 280,675 | 86,783 | Feb 16, 2016, 04:25 PM |
| KING DAVID P | President & CEO | Feb 12, 2016 | Option Exercise | $103.02 | 3,735 | 384,780 | 91,318 | Feb 16, 2016, 04:25 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 12, 2016 | Option Exercise | $103.02 | 182 | 18,750 | 7,497 | Feb 16, 2016, 04:24 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 11, 2016 | Option Exercise | $101.40 | 212 | 21,497 | 7,132 | Feb 16, 2016, 04:24 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 12, 2016 | Option Exercise | $103.02 | 512 | 52,746 | 6,748 | Feb 16, 2016, 04:23 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 11, 2016 | Option Exercise | $101.40 | 555 | 56,277 | 5,720 | Feb 16, 2016, 04:23 PM |
| BERBERIAN LANCE | SVP, Chief Information Officer | Feb 11, 2016 | Option Exercise | $101.40 | 513 | 52,018 | 1,938 | Feb 16, 2016, 04:22 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 12, 2016 | Option Exercise | $103.02 | 177 | 18,235 | 18,436 | Feb 16, 2016, 04:21 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 11, 2016 | Option Exercise | $101.40 | 228 | 23,119 | 18,471 | Feb 16, 2016, 04:21 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 12, 2016 | Sale | $101.67 | 405 | 41,176 | 18,066 | Feb 16, 2016, 04:21 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Jan 08, 2016 | Sale | $119.05 | 1,215 | 144,646 | 18,066 | Jan 12, 2016, 04:51 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Dec 08, 2015 | Sale | $123.31 | 1,010 | 124,543 | 19,281 | Dec 10, 2015, 04:38 PM |
| Williams R Sanders | Director | Nov 02, 2015 | Option Exercise | $64.42 | 1,850 | 119,177 | 6,026 | Nov 04, 2015, 03:20 PM |
| Williams R Sanders | Director | Nov 02, 2015 | Sale | $124.30 | 1,850 | 229,949 | 5,076 | Nov 04, 2015, 03:20 PM |
| ANDERSON KERRII B | Director | Oct 29, 2015 | Option Exercise | $59.37 | 1,296 | 76,944 | 13,035 | Nov 02, 2015, 02:31 PM |
| KING DAVID P | President & CEO | Aug 03, 2015 | Option Exercise | $80.37 | 50,000 | 4,018,500 | 131,153 | Aug 05, 2015, 03:53 PM |
| KING DAVID P | President & CEO | Aug 03, 2015 | Sale | $127.93 | 50,000 | 6,396,358 | 97,453 | Aug 05, 2015, 03:53 PM |
| HERRING JOSEPH L | CEO of Covance Drug Division | Jul 31, 2015 | Option Exercise | $127.29 | 9,586 | 1,220,202 | 10,404 | Aug 04, 2015, 02:15 PM |
| KING DAVID P | President & CEO | Jul 01, 2015 | Option Exercise | $80.37 | 50,000 | 4,018,500 | 116,063 | Jul 06, 2015, 09:08 PM |
| KING DAVID P | President & CEO | Jul 01, 2015 | Sale | $121.78 | 50,000 | 6,089,040 | 95,553 | Jul 06, 2015, 09:08 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Jun 16, 2015 | Option Exercise | $120.48 | 1,596 | 192,286 | 4,602 | Jun 18, 2015, 04:07 PM |
| KING DAVID P | President & CEO | Jun 01, 2015 | Option Exercise | $80.37 | 50,000 | 4,018,500 | 115,899 | Jun 03, 2015, 04:17 PM |
| KING DAVID P | President & CEO | Jun 01, 2015 | Sale | $118.58 | 50,000 | 5,928,845 | 114,990 | Jun 03, 2015, 04:17 PM |
| MITTELSTAEDT ROBERT E JR | Director | May 19, 2015 | Option Exercise | $59.37 | 1,296 | 76,944 | 11,407 | May 21, 2015, 01:30 PM |
| MITTELSTAEDT ROBERT E JR | Director | May 19, 2015 | Sale | $119.02 | 1,296 | 154,254 | 11,007 | May 21, 2015, 01:30 PM |
| Williams R Sanders | Director | May 11, 2015 | Sale | $118.05 | 965 | 113,914 | 4,678 | May 14, 2015, 10:58 AM |
| BELINGARD JEAN-LUC | Director | Apr 29, 2015 | Option Exercise | $49.93 | 1,542 | 76,992 | 30,968 | May 01, 2015, 05:14 PM |
| BELINGARD JEAN-LUC | Director | Apr 29, 2015 | Sale | $123.10 | 1,542 | 189,820 | 29,426 | May 01, 2015, 05:14 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Apr 23, 2015 | Sale | $126.56 | 1,394 | 176,425 | 24,648 | Apr 27, 2015, 05:28 PM |
| Brecher Mark E | CMO, LabCorp Diagnostics | Mar 30, 2015 | Option Exercise | $127.28 | 172 | 21,892 | 6,936 | Apr 01, 2015, 08:35 PM |
| Brecher Mark E | CMO, LabCorp Diagnostics | Mar 30, 2015 | Option Exercise | $88.41 | 19,200 | 1,697,520 | 26,136 | Apr 01, 2015, 08:35 PM |
| Brecher Mark E | CMO, LabCorp Diagnostics | Mar 31, 2015 | Sale | $127.00 | 347 | 44,069 | 5,511 | Apr 01, 2015, 08:35 PM |
| Brecher Mark E | CMO, LabCorp Diagnostics | Mar 30, 2015 | Sale | $126.98 | 20,278 | 2,574,921 | 5,858 | Apr 01, 2015, 08:35 PM |
| KING DAVID P | President & CEO | Mar 30, 2015 | Option Exercise | $127.28 | 3,974 | 505,811 | 65,899 | Apr 01, 2015, 07:50 PM |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | Mar 30, 2015 | Option Exercise | $127.28 | 1,272 | 161,900 | 24,848 | Apr 01, 2015, 07:48 PM |
| Dodson Edward T | Principal Accounting Officer | Mar 30, 2015 | Option Exercise | $127.28 | 172 | 21,892 | 6,575 | Apr 01, 2015, 07:46 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 30, 2015 | Option Exercise | $127.28 | 172 | 21,892 | 20,291 | Apr 01, 2015, 07:44 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 02, 2015 | Option Exercise | $123.36 | 1,130 | 139,397 | 24,691 | Mar 04, 2015, 10:38 AM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 03, 2015 | Sale | $123.70 | 1,237 | 153,015 | 24,654 | Mar 04, 2015, 10:38 AM |
| Dodson Edward T | Principal Accounting Officer | Mar 02, 2015 | Option Exercise | $123.36 | 154 | 18,997 | 6,228 | Mar 04, 2015, 10:37 AM |
| Brecher Mark E | Chief Medical Officer | Mar 02, 2015 | Option Exercise | $123.36 | 154 | 18,997 | 6,589 | Mar 04, 2015, 10:36 AM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 02, 2015 | Option Exercise | $123.36 | 155 | 19,121 | 19,944 | Mar 04, 2015, 10:35 AM |
| KING DAVID P | President & CEO | Mar 02, 2015 | Option Exercise | $123.36 | 3,515 | 433,610 | 61,543 | Mar 04, 2015, 10:33 AM |
| Williams R Sanders | Director | Feb 26, 2015 | Sale | $123.96 | 2,267 | 281,025 | 6,441 | Mar 02, 2015, 04:26 PM |
| HERRING JOSEPH L | CEO of Covance Drug Division | Feb 25, 2015 | Sale | $121.64 | 36,876 | 4,485,436 | 6,158 | Feb 27, 2015, 06:32 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 12, 2015 | Option Exercise | $116.84 | 178 | 20,798 | 6,382 | Feb 17, 2015, 04:06 PM |
| KING DAVID P | President & CEO | Feb 12, 2015 | Option Exercise | $116.84 | 3,945 | 460,934 | 65,058 | Feb 17, 2015, 04:05 PM |
| Brecher Mark E | Chief Medical Officer | Feb 12, 2015 | Option Exercise | $116.84 | 177 | 20,681 | 6,743 | Feb 17, 2015, 04:01 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 12, 2015 | Option Exercise | $116.84 | 178 | 20,798 | 20,099 | Feb 17, 2015, 03:58 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 12, 2015 | Option Exercise | $116.84 | 510 | 59,588 | 2,148 | Feb 17, 2015, 03:57 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 12, 2015 | Option Exercise | $116.84 | 2,287 | 267,213 | 29,704 | Feb 17, 2015, 03:55 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 13, 2015 | Sale | $116.66 | 3,883 | 452,991 | 27,807 | Feb 17, 2015, 03:55 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 12, 2015 | Sale | $116.71 | 2,714 | 316,751 | 25,821 | Feb 17, 2015, 03:55 PM |
| Dodson Edward T | Principal Accounting Officer | Feb 11, 2015 | Option Exercise | $116.73 | 212 | 24,747 | 6,013 | Feb 13, 2015, 05:44 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 11, 2015 | Option Exercise | $116.73 | 1,342 | 156,652 | 28,535 | Feb 13, 2015, 05:10 PM |
| Brecher Mark E | Chief Medical Officer | Feb 11, 2015 | Option Exercise | $116.73 | 213 | 24,863 | 6,373 | Feb 13, 2015, 04:54 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 11, 2015 | Option Exercise | $116.73 | 228 | 26,614 | 19,730 | Feb 13, 2015, 04:44 PM |
| EISENBERG GLENN A | Chief Financial Officer, EVP | Feb 11, 2015 | Option Exercise | $116.73 | 555 | 64,785 | 1,118 | Feb 13, 2015, 04:40 PM |
| KING DAVID P | President & CEO | Feb 11, 2015 | Option Exercise | $116.73 | 3,262 | 380,773 | 60,733 | Feb 13, 2015, 04:39 PM |
| BELINGARD JEAN-LUC | Director | Feb 10, 2015 | Option Exercise | $115.39 | 151 | 17,424 | 29,426 | Feb 12, 2015, 04:07 PM |
| KING DAVID P | President & CEO | Sep 22, 2014 | Option Exercise | $75.63 | 65,234 | 4,933,647 | 120,817 | Sep 24, 2014, 11:44 AM |
| KING DAVID P | President & CEO | Sep 22, 2014 | Sale | $104.71 | 65,234 | 6,830,741 | 60,283 | Sep 24, 2014, 11:44 AM |
| Williams R Sanders | Director | Sep 05, 2014 | Sale | $107.95 | 2,000 | 215,906 | 6,505 | Sep 09, 2014, 03:35 PM |
| KING DAVID P | President & CEO | Aug 22, 2014 | Option Exercise | $75.63 | 65,233 | 4,933,572 | 120,816 | Aug 26, 2014, 02:38 PM |
| KING DAVID P | President & CEO | Aug 22, 2014 | Sale | $106.10 | 65,233 | 6,921,482 | 55,583 | Aug 26, 2014, 02:38 PM |
| KING DAVID P | President & CEO | Jul 22, 2014 | Option Exercise | $75.63 | 65,233 | 4,933,572 | 120,816 | Jul 24, 2014, 04:43 PM |
| KING DAVID P | President & CEO | Jul 22, 2014 | Sale | $105.55 | 65,233 | 6,885,411 | 57,183 | Jul 24, 2014, 04:43 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Jun 09, 2014 | Option Exercise | $84.86 | 38,600 | 3,275,596 | 64,421 | Jun 10, 2014, 04:25 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Jun 09, 2014 | Sale | $103.00 | 38,600 | 3,975,800 | 25,821 | Jun 10, 2014, 04:25 PM |
| Hayes William B | Chief Financial Officer, EVP | Jun 06, 2014 | Option Exercise | $88.36 | 47,367 | 4,185,380 | 66,767 | Jun 10, 2014, 04:24 PM |
| Hayes William B | Chief Financial Officer, EVP | Jun 06, 2014 | Sale | $104.23 | 47,367 | 4,936,965 | 41,500 | Jun 10, 2014, 04:24 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Jun 06, 2014 | Option Exercise | $60.04 | 10,000 | 600,400 | 29,325 | Jun 10, 2014, 04:12 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Jun 06, 2014 | Sale | $104.37 | 10,000 | 1,043,700 | 19,325 | Jun 10, 2014, 04:12 PM |
| Brecher Mark E | Chief Medical Officer | Jun 04, 2014 | Sale | $102.31 | 2,600 | 266,006 | 5,754 | Jun 06, 2014, 02:53 PM |
| Williams R Sanders | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 7,905 | May 12, 2014, 05:11 PM |
| Rubenstein Arthur H | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 11,772 | May 12, 2014, 05:10 PM |
| Schechter Adam H | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 1,734 | May 12, 2014, 05:07 PM |
| NEUPERT PETER M | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 2,168 | May 12, 2014, 05:05 PM |
| MITTELSTAEDT ROBERT E JR | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 8,608 | May 12, 2014, 05:04 PM |
| LANE WENDY E | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 18,988 | May 12, 2014, 05:03 PM |
| BELINGARD JEAN-LUC | Director | May 08, 2014 | Option Exercise | $98.96 | 160 | 15,834 | 28,074 | May 12, 2014, 05:00 PM |
| BELINGARD JEAN-LUC | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 28,234 | May 12, 2014, 05:00 PM |
| ANDERSON KERRII B | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 10,236 | May 12, 2014, 04:56 PM |
| WEIKEL M KEITH | Director | May 07, 2014 | Option Exercise | $38.80 | 1,984 | 76,979 | 14,349 | May 09, 2014, 03:35 PM |
| WEIKEL M KEITH | Director | May 08, 2014 | Option Exercise | $98.96 | 1,593 | 157,643 | 13,958 | May 09, 2014, 03:35 PM |
| WEIKEL M KEITH | Director | May 07, 2014 | Sale | $98.28 | 1,984 | 194,979 | 13,248 | May 09, 2014, 03:35 PM |
| BELINGARD JEAN-LUC | Director | Apr 30, 2014 | Option Exercise | $38.80 | 1,984 | 76,979 | 28,625 | May 02, 2014, 05:13 PM |
| BELINGARD JEAN-LUC | Director | Apr 30, 2014 | Sale | $98.68 | 1,984 | 195,782 | 28,525 | May 02, 2014, 05:13 PM |
| Hayes William B | Chief Financial Officer, EVP | Apr 30, 2014 | Sale | $98.39 | 2,497 | 245,680 | 19,400 | May 02, 2014, 05:12 PM |
| LANE WENDY E | Director | Apr 30, 2014 | Option Exercise | $38.80 | 992 | 38,490 | 17,785 | May 02, 2014, 05:11 PM |
| LANE WENDY E | Director | Apr 30, 2014 | Sale | $98.97 | 390 | 38,599 | 17,395 | May 02, 2014, 05:11 PM |
| MITTELSTAEDT ROBERT E JR | Director | Apr 30, 2014 | Option Exercise | $43.67 | 3,526 | 153,971 | 8,999 | May 02, 2014, 05:10 PM |
| MITTELSTAEDT ROBERT E JR | Director | Apr 30, 2014 | Sale | $98.39 | 3,526 | 346,923 | 7,015 | May 02, 2014, 05:10 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 27, 2014 | Option Exercise | $97.87 | 2,304 | 225,492 | 28,342 | Mar 31, 2014, 03:55 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 28, 2014 | Sale | $98.36 | 2,521 | 247,966 | 25,821 | Mar 31, 2014, 03:55 PM |
| Brecher Mark E | Chief Medical Officer | Mar 27, 2014 | Option Exercise | $97.87 | 329 | 32,199 | 8,354 | Mar 31, 2014, 03:53 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 27, 2014 | Option Exercise | $97.87 | 329 | 32,199 | 19,325 | Mar 31, 2014, 03:52 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 27, 2014 | Option Exercise | $97.87 | 2,283 | 223,437 | 21,897 | Mar 31, 2014, 03:51 PM |
| KING DAVID P | President & CEO | Mar 27, 2014 | Option Exercise | $97.87 | 7,193 | 703,979 | 70,147 | Mar 31, 2014, 03:50 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 07, 2014 | Option Exercise | $84.86 | 19,166 | 1,626,427 | 38,566 | Mar 10, 2014, 08:57 AM |
| Hayes William B | Chief Financial Officer, EVP | Mar 07, 2014 | Sale | $94.50 | 19,166 | 1,811,187 | 19,400 | Mar 10, 2014, 08:57 AM |
| Hayes William B | Chief Financial Officer, EVP | Mar 06, 2014 | Sale | $94.00 | 4,682 | 440,119 | 23,802 | Mar 10, 2014, 08:57 AM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 03, 2014 | Sale | $93.06 | 1,582 | 147,221 | 25,821 | Mar 10, 2014, 08:54 AM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 28, 2014 | Option Exercise | $93.54 | 785 | 73,429 | 27,403 | Mar 04, 2014, 02:00 PM |
| Brecher Mark E | Chief Medical Officer | Feb 28, 2014 | Option Exercise | $93.54 | 151 | 14,125 | 7,691 | Mar 04, 2014, 01:58 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 28, 2014 | Option Exercise | $93.54 | 774 | 72,400 | 24,082 | Mar 04, 2014, 01:57 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 28, 2014 | Option Exercise | $93.54 | 151 | 14,125 | 18,662 | Mar 04, 2014, 01:55 PM |
| KING DAVID P | President & CEO | Feb 28, 2014 | Option Exercise | $93.54 | 3,518 | 329,074 | 62,277 | Mar 04, 2014, 01:53 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 12, 2014 | Option Exercise | $90.98 | 2,046 | 186,145 | 32,311 | Feb 14, 2014, 07:29 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 13, 2014 | Sale | $90.29 | 4,123 | 372,266 | 30,416 | Feb 14, 2014, 07:29 PM |
| KING DAVID P | President & CEO | Feb 12, 2014 | Option Exercise | $90.98 | 3,949 | 359,280 | 65,795 | Feb 13, 2014, 07:39 PM |
| Brecher Mark E | Chief Medical Officer | Feb 12, 2014 | Option Exercise | $90.98 | 194 | 17,650 | 7,842 | Feb 13, 2014, 07:36 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 12, 2014 | Option Exercise | $90.98 | 184 | 16,740 | 18,813 | Feb 13, 2014, 07:34 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 12, 2014 | Option Exercise | $90.98 | 934 | 84,975 | 24,856 | Feb 13, 2014, 07:30 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 10, 2014 | Option Exercise | $91.35 | 142 | 12,972 | 18,451 | Feb 12, 2014, 03:40 PM |
| Brecher Mark E | Chief Medical Officer | Feb 10, 2014 | Option Exercise | $91.35 | 142 | 12,972 | 7,490 | Feb 12, 2014, 03:30 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 10, 2014 | Option Exercise | $91.35 | 600 | 54,810 | 22,974 | Feb 12, 2014, 03:28 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 10, 2014 | Option Exercise | $91.35 | 596 | 54,445 | 29,392 | Feb 12, 2014, 03:27 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 11, 2014 | Sale | $91.15 | 1,204 | 109,745 | 28,188 | Feb 12, 2014, 03:27 PM |
| KING DAVID P | President & CEO | Feb 10, 2014 | Option Exercise | $91.35 | 2,225 | 203,254 | 61,474 | Feb 12, 2014, 03:22 PM |
| KING DAVID P | President & CEO | Jan 27, 2014 | Option Exercise | $60.04 | 24,200 | 1,452,968 | 87,899 | Jan 29, 2014, 03:18 PM |
| KING DAVID P | President & CEO | Jan 27, 2014 | Sale | $90.15 | 24,200 | 2,181,637 | 63,699 | Jan 29, 2014, 03:18 PM |
| KING DAVID P | President & CEO | Dec 24, 2013 | Option Exercise | $60.04 | 25,000 | 1,501,000 | 88,628 | Dec 27, 2013, 04:50 PM |
| KING DAVID P | President & CEO | Dec 24, 2013 | Sale | $90.79 | 25,000 | 2,269,750 | 63,628 | Dec 27, 2013, 04:50 PM |
| Brecher Mark E | Chief Medical Officer | Nov 25, 2013 | Sale | $105.62 | 400 | 42,248 | 7,585 | Nov 27, 2013, 10:59 AM |
| KING DAVID P | President & CEO | Nov 25, 2013 | Option Exercise | $60.04 | 25,000 | 1,501,000 | 88,628 | Nov 27, 2013, 09:55 AM |
| KING DAVID P | President & CEO | Nov 25, 2013 | Sale | $106.01 | 25,000 | 2,650,300 | 63,628 | Nov 27, 2013, 09:55 AM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Nov 11, 2013 | Option Exercise | $58.57 | 10,000 | 585,700 | 28,593 | Nov 13, 2013, 01:54 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Nov 11, 2013 | Sale | $105.83 | 10,000 | 1,058,350 | 18,593 | Nov 13, 2013, 01:54 PM |
| KING DAVID P | President & CEO | Oct 24, 2013 | Option Exercise | $60.04 | 25,000 | 1,501,000 | 88,628 | Oct 28, 2013, 09:14 AM |
| KING DAVID P | President & CEO | Oct 24, 2013 | Sale | $100.91 | 25,000 | 2,522,801 | 68,041 | Oct 28, 2013, 09:14 AM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Oct 17, 2013 | Option Exercise | $77.57 | 24,400 | 1,892,772 | 44,388 | Oct 21, 2013, 02:59 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Oct 17, 2013 | Sale | $102.00 | 24,400 | 2,488,800 | 29,988 | Oct 21, 2013, 02:59 PM |
| KING DAVID P | President & CEO | Sep 25, 2013 | Option Exercise | $60.04 | 25,000 | 1,501,000 | 88,628 | Sep 27, 2013, 10:45 AM |
| KING DAVID P | President & CEO | Sep 25, 2013 | Sale | $99.06 | 25,000 | 2,476,615 | 63,628 | Sep 27, 2013, 10:45 AM |
| KING DAVID P | President & CEO | Aug 26, 2013 | Option Exercise | $60.04 | 25,000 | 1,501,000 | 88,628 | Aug 28, 2013, 12:01 PM |
| KING DAVID P | President & CEO | Aug 26, 2013 | Sale | $96.60 | 25,000 | 2,415,047 | 63,628 | Aug 28, 2013, 12:01 PM |
| MITTELSTAEDT ROBERT E JR | Director | Aug 21, 2013 | Sale | $96.86 | 7,429 | 719,592 | 14,244 | Aug 23, 2013, 10:09 AM |
| KING DAVID P | President & CEO | Jul 24, 2013 | Option Exercise | $60.04 | 25,000 | 1,501,000 | 88,628 | Jul 26, 2013, 03:56 PM |
| KING DAVID P | President & CEO | Jul 24, 2013 | Sale | $97.72 | 25,000 | 2,442,897 | 63,628 | Jul 26, 2013, 03:56 PM |
| KING DAVID P | President & CEO | Jun 24, 2013 | Option Exercise | $60.04 | 25,000 | 1,501,000 | 88,423 | Jun 26, 2013, 05:38 PM |
| KING DAVID P | President & CEO | Jun 24, 2013 | Sale | $98.66 | 25,000 | 2,466,533 | 64,123 | Jun 26, 2013, 05:38 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Jun 07, 2013 | Option Exercise | $70.15 | 63,100 | 4,426,465 | 93,088 | Jun 11, 2013, 02:19 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Jun 07, 2013 | Sale | $99.63 | 63,100 | 6,286,653 | 29,988 | Jun 11, 2013, 02:19 PM |
| Brecher Mark E | Chief Medical Officer | May 28, 2013 | Option Exercise | $70.15 | 14,900 | 1,045,235 | 24,653 | May 30, 2013, 04:34 PM |
| Brecher Mark E | Chief Medical Officer | May 28, 2013 | Sale | $100.92 | 16,900 | 1,705,548 | 7,753 | May 30, 2013, 04:34 PM |
| BELINGARD JEAN-LUC | Director | May 24, 2013 | Option Exercise | $100.37 | 60 | 6,022 | 26,641 | May 29, 2013, 04:35 PM |
| Hayes William B | Chief Financial Officer, EVP | May 21, 2013 | Option Exercise | $77.68 | 127,200 | 9,880,836 | 95,774 | May 23, 2013, 04:05 PM |
| Hayes William B | Chief Financial Officer, EVP | May 21, 2013 | Sale | $100.00 | 127,200 | 12,720,000 | 23,574 | May 23, 2013, 04:05 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | May 17, 2013 | Option Exercise | $47.89 | 10,000 | 478,900 | 28,593 | May 21, 2013, 05:26 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | May 17, 2013 | Sale | $98.47 | 10,000 | 984,700 | 18,593 | May 21, 2013, 05:26 PM |
| BELINGARD JEAN-LUC | Director | May 13, 2013 | Option Exercise | $95.01 | 54 | 5,131 | 26,701 | May 15, 2013, 05:03 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | May 10, 2013 | Option Exercise | $59.13 | 60,734 | 3,591,261 | 98,896 | May 14, 2013, 04:37 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | May 10, 2013 | Sale | $93.82 | 68,908 | 6,464,866 | 29,988 | May 14, 2013, 04:37 PM |
| BELINGARD JEAN-LUC | Director | May 08, 2013 | Option Exercise | $30.36 | 2,536 | 76,993 | 29,291 | May 10, 2013, 07:56 AM |
| BELINGARD JEAN-LUC | Director | May 08, 2013 | Sale | $92.88 | 2,536 | 235,544 | 26,755 | May 10, 2013, 07:56 AM |
| WEIKEL M KEITH | Director | May 03, 2013 | Option Exercise | $31.35 | 2,046 | 64,142 | 14,411 | May 06, 2013, 12:35 PM |
| WEIKEL M KEITH | Director | May 03, 2013 | Sale | $92.91 | 2,046 | 190,086 | 12,965 | May 06, 2013, 12:35 PM |
| LANE WENDY E | Director | Apr 29, 2013 | Option Exercise | $93.73 | 412 | 38,617 | 16,831 | May 01, 2013, 03:37 PM |
| LANE WENDY E | Director | Apr 29, 2013 | Option Exercise | $30.36 | 1,268 | 38,496 | 17,205 | May 01, 2013, 03:37 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Apr 25, 2013 | Sale | $93.84 | 1,500 | 140,760 | 18,593 | Apr 29, 2013, 03:49 PM |
| Williams R Sanders | Director | Apr 24, 2013 | Option Exercise | $64.42 | 1,850 | 119,177 | 8,162 | Apr 25, 2013, 01:13 PM |
| Williams R Sanders | Director | Apr 24, 2013 | Sale | $93.77 | 1,850 | 173,477 | 6,932 | Apr 25, 2013, 01:13 PM |
| Hayes William B | Chief Financial Officer, EVP | Apr 11, 2013 | Option Exercise | $70.15 | 22,234 | 1,559,715 | 45,808 | Apr 15, 2013, 03:37 PM |
| Hayes William B | Chief Financial Officer, EVP | Apr 11, 2013 | Sale | $95.00 | 22,234 | 2,112,230 | 23,574 | Apr 15, 2013, 03:37 PM |
| KING DAVID P | President & CEO | Mar 28, 2013 | Option Exercise | $90.20 | 17,180 | 1,549,636 | 63,423 | Apr 01, 2013, 03:47 PM |
| Fonseca Lidia | Chief Information Officer | Mar 28, 2013 | Option Exercise | $90.20 | 872 | 78,654 | 9,087 | Apr 01, 2013, 03:45 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 28, 2013 | Option Exercise | $90.20 | 872 | 78,654 | 20,093 | Apr 01, 2013, 03:44 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 28, 2013 | Option Exercise | $90.20 | 5,580 | 503,316 | 28,523 | Apr 01, 2013, 03:43 PM |
| Brecher Mark E | Chief Medical Officer | Mar 28, 2013 | Option Exercise | $90.20 | 903 | 81,451 | 9,753 | Apr 01, 2013, 03:41 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 28, 2013 | Option Exercise | $90.20 | 5,484 | 494,657 | 38,162 | Apr 01, 2013, 03:32 PM |
| KING DAVID P | President & CEO | Feb 28, 2013 | Option Exercise | $88.60 | 3,533 | 313,024 | 44,776 | Mar 04, 2013, 02:32 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 28, 2013 | Option Exercise | $88.60 | 790 | 69,994 | 32,171 | Mar 04, 2013, 02:30 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 28, 2013 | Option Exercise | $88.60 | 779 | 69,019 | 21,974 | Mar 04, 2013, 02:29 PM |
| Brecher Mark E | Chief Medical Officer | Feb 28, 2013 | Option Exercise | $88.60 | 156 | 13,822 | 7,951 | Mar 04, 2013, 02:27 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 28, 2013 | Option Exercise | $88.60 | 156 | 13,822 | 18,353 | Mar 04, 2013, 02:26 PM |
| Fonseca Lidia | Chief Information Officer | Feb 28, 2013 | Option Exercise | $88.60 | 156 | 13,822 | 7,347 | Mar 04, 2013, 02:24 PM |
| KING DAVID P | President & CEO | Feb 11, 2013 | Option Exercise | $90.06 | 4,115 | 370,597 | 50,292 | Feb 13, 2013, 05:17 PM |
| Brecher Mark E | Chief Medical Officer | Feb 11, 2013 | Option Exercise | $90.06 | 322 | 28,999 | 8,235 | Feb 13, 2013, 05:15 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 11, 2013 | Option Exercise | $90.06 | 310 | 27,919 | 18,638 | Feb 13, 2013, 05:10 PM |
| Fonseca Lidia | Chief Information Officer | Feb 11, 2013 | Option Exercise | $90.06 | 310 | 27,919 | 7,632 | Feb 13, 2013, 05:06 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 11, 2013 | Option Exercise | $90.06 | 1,298 | 116,898 | 33,562 | Feb 13, 2013, 05:04 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 11, 2013 | Option Exercise | $90.06 | 1,325 | 119,329 | 23,343 | Feb 13, 2013, 05:03 PM |
| MAC MAHON THOMAS P | Director | Sep 06, 2012 | Sale | $89.74 | 35,000 | 3,141,044 | 32,297 | Sep 10, 2012, 11:10 AM |
| MITTELSTAEDT ROBERT E JR | Director | Aug 27, 2012 | Option Exercise | $30.36 | 2,536 | 76,993 | 16,980 | Aug 29, 2012, 03:01 PM |
| MITTELSTAEDT ROBERT E JR | Director | Aug 27, 2012 | Sale | $88.61 | 2,536 | 224,715 | 14,444 | Aug 29, 2012, 03:01 PM |
| Brecher Mark E | Chief Medical Officer | Jul 13, 2012 | Option Exercise | $60.04 | 19,200 | 1,152,768 | 28,716 | Jul 17, 2012, 03:05 PM |
| Brecher Mark E | Chief Medical Officer | Jul 13, 2012 | Sale | $95.00 | 20,341 | 1,932,395 | 9,516 | Jul 17, 2012, 03:05 PM |
| Fonseca Lidia | Chief Information Officer | Jul 13, 2012 | Option Exercise | $60.04 | 18,200 | 1,092,728 | 26,013 | Jul 17, 2012, 03:02 PM |
| Fonseca Lidia | Chief Information Officer | Jul 13, 2012 | Sale | $95.00 | 18,200 | 1,729,000 | 7,813 | Jul 17, 2012, 03:02 PM |
| KING DAVID P | President & CEO | Jul 09, 2012 | Option Exercise | $59.43 | 84,800 | 5,039,942 | 195,032 | Jul 11, 2012, 02:54 PM |
| KING DAVID P | President & CEO | Jul 09, 2012 | Sale | $92.11 | 84,800 | 7,810,928 | 110,232 | Jul 11, 2012, 02:54 PM |
| Fonseca Lidia | Chief Information Officer | Jun 27, 2012 | Sale | $90.00 | 1,687 | 151,830 | 7,813 | Jun 29, 2012, 03:36 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Jun 04, 2012 | Sale | $83.83 | 2,678 | 224,504 | 19,119 | Jun 06, 2012, 05:08 PM |
| BELINGARD JEAN-LUC | Director | May 14, 2012 | Option Exercise | $85.33 | 30 | 2,560 | 24,955 | May 15, 2012, 01:41 PM |
| BELINGARD JEAN-LUC | Director | May 11, 2012 | Option Exercise | $86.72 | 24 | 2,081 | 24,985 | May 15, 2012, 01:41 PM |
| LANE WENDY E | Director | May 09, 2012 | Option Exercise | $48.02 | 677 | 32,510 | 14,480 | May 11, 2012, 02:36 PM |
| LANE WENDY E | Director | May 09, 2012 | Sale | $85.98 | 510 | 43,851 | 14,470 | May 11, 2012, 02:36 PM |
| LANE WENDY E | Director | May 08, 2012 | Option Exercise | $64.42 | 617 | 39,747 | 14,587 | May 10, 2012, 09:37 AM |
| LANE WENDY E | Director | May 08, 2012 | Sale | $86.46 | 800 | 69,170 | 14,070 | May 10, 2012, 09:37 AM |
| BELINGARD JEAN-LUC | Director | May 07, 2012 | Option Exercise | $87.04 | 37 | 3,220 | 25,009 | May 09, 2012, 10:46 AM |
| BELINGARD JEAN-LUC | Director | May 01, 2012 | Option Exercise | $48.02 | 1,353 | 64,971 | 26,399 | May 03, 2012, 03:39 PM |
| BELINGARD JEAN-LUC | Director | May 01, 2012 | Sale | $88.11 | 1,353 | 119,218 | 26,151 | May 03, 2012, 03:39 PM |
| Walton Andrew Scott | EVP | Apr 09, 2012 | Sale | $91.82 | 4,000 | 367,280 | 24,298 | Apr 11, 2012, 02:57 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 26, 2012 | Option Exercise | $91.90 | 8,315 | 764,149 | 37,320 | Mar 28, 2012, 04:35 PM |
| KING DAVID P | President & CEO | Mar 26, 2012 | Option Exercise | $91.90 | 27,690 | 2,544,711 | 153,784 | Mar 28, 2012, 04:31 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 26, 2012 | Option Exercise | $91.90 | 10,137 | 931,590 | 37,819 | Mar 28, 2012, 04:23 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 26, 2012 | Option Exercise | $70.15 | 2,750 | 192,913 | 26,828 | Mar 28, 2012, 04:23 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 27, 2012 | Sale | $91.67 | 13,741 | 1,259,587 | 24,078 | Mar 28, 2012, 04:23 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 26, 2012 | Sale | $90.00 | 2,750 | 247,500 | 24,078 | Mar 28, 2012, 04:23 PM |
| Walton Andrew Scott | EVP | Mar 26, 2012 | Option Exercise | $91.90 | 4,999 | 459,408 | 26,298 | Mar 28, 2012, 04:22 PM |
| Brecher Mark E | Chief Medical Officer | Mar 26, 2012 | Option Exercise | $91.90 | 1,607 | 147,683 | 9,286 | Mar 28, 2012, 04:17 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 26, 2012 | Option Exercise | $91.90 | 1,559 | 143,272 | 21,497 | Mar 28, 2012, 04:16 PM |
| Fonseca Lidia | Chief Information Officer | Mar 26, 2012 | Option Exercise | $91.90 | 1,559 | 143,272 | 9,500 | Mar 28, 2012, 04:15 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 23, 2012 | Option Exercise | $65.89 | 72,083 | 4,749,612 | 100,648 | Mar 27, 2012, 03:58 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 23, 2012 | Sale | $89.68 | 76,570 | 6,866,831 | 83,941 | Mar 27, 2012, 03:58 PM |
| MAC MAHON THOMAS P | Director | Feb 29, 2012 | Sale | $89.98 | 60,000 | 5,398,812 | 65,497 | Mar 02, 2012, 03:26 PM |
| Walton Andrew Scott | EVP | Feb 09, 2012 | Option Exercise | $92.11 | 726 | 66,872 | 18,001 | Feb 13, 2012, 03:38 PM |
| Walton Andrew Scott | EVP | Feb 10, 2012 | Option Exercise | $90.03 | 466 | 41,954 | 17,221 | Feb 13, 2012, 03:38 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 10, 2012 | Option Exercise | $90.03 | 888 | 79,947 | 21,565 | Feb 13, 2012, 03:37 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 09, 2012 | Option Exercise | $92.11 | 1,292 | 119,006 | 23,027 | Feb 13, 2012, 03:37 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 10, 2012 | Option Exercise | $90.03 | 466 | 41,954 | 15,888 | Feb 13, 2012, 03:36 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 09, 2012 | Option Exercise | $92.11 | 1,268 | 116,795 | 16,939 | Feb 13, 2012, 03:36 PM |
| KING DAVID P | President & CEO | Feb 09, 2012 | Option Exercise | $92.11 | 4,721 | 434,851 | 99,679 | Feb 13, 2012, 03:36 PM |
| KING DAVID P | President & CEO | Feb 10, 2012 | Option Exercise | $90.03 | 3,170 | 285,395 | 94,146 | Feb 13, 2012, 03:36 PM |
| Fonseca Lidia | Chief Information Officer | Feb 10, 2012 | Option Exercise | $90.03 | 174 | 15,665 | 4,855 | Feb 13, 2012, 03:34 PM |
| Fonseca Lidia | Chief Information Officer | Feb 09, 2012 | Option Exercise | $92.11 | 296 | 27,265 | 5,153 | Feb 13, 2012, 03:34 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 10, 2012 | Option Exercise | $90.03 | 174 | 15,665 | 17,072 | Feb 13, 2012, 03:34 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 09, 2012 | Option Exercise | $92.11 | 296 | 27,265 | 17,370 | Feb 13, 2012, 03:34 PM |
| Brecher Mark E | Chief Medical Officer | Feb 10, 2012 | Option Exercise | $90.03 | 184 | 16,566 | 4,543 | Feb 13, 2012, 03:33 PM |
| Brecher Mark E | Chief Medical Officer | Feb 09, 2012 | Option Exercise | $92.11 | 751 | 69,175 | 5,294 | Feb 13, 2012, 03:33 PM |
| KING DAVID P | President & CEO | Jan 25, 2012 | Option Exercise | $58.57 | 20,000 | 1,171,400 | 122,037 | Jan 27, 2012, 04:09 PM |
| KING DAVID P | President & CEO | Jan 25, 2012 | Sale | $92.00 | 20,000 | 1,840,000 | 102,037 | Jan 27, 2012, 04:09 PM |
| KING DAVID P | President & CEO | Dec 02, 2011 | Option Exercise | $47.89 | 20,000 | 957,800 | 121,957 | Dec 06, 2011, 02:57 PM |
| KING DAVID P | President & CEO | Dec 02, 2011 | Sale | $88.00 | 20,000 | 1,760,000 | 101,957 | Dec 06, 2011, 02:57 PM |
| MITTELSTAEDT ROBERT E JR | Director | Aug 18, 2011 | Option Exercise | $48.02 | 1,353 | 64,971 | 12,925 | Aug 22, 2011, 01:51 PM |
| MITTELSTAEDT ROBERT E JR | Director | Aug 18, 2011 | Sale | $79.96 | 817 | 65,329 | 12,108 | Aug 22, 2011, 01:51 PM |
| Williams R Sanders | Director | May 19, 2011 | Option Exercise | $75.94 | 6,292 | 477,798 | 9,812 | May 23, 2011, 01:01 PM |
| Williams R Sanders | Director | May 19, 2011 | Sale | $100.73 | 6,292 | 633,769 | 8,912 | May 23, 2011, 01:01 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | May 13, 2011 | Option Exercise | $78.75 | 15,200 | 1,196,976 | 32,742 | May 17, 2011, 03:10 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | May 13, 2011 | Sale | $99.04 | 15,200 | 1,505,479 | 17,542 | May 17, 2011, 03:10 PM |
| BELINGARD JEAN-LUC | Director | May 12, 2011 | Option Exercise | $100.00 | 30 | 3,000 | 25,046 | May 13, 2011, 05:23 PM |
| BELINGARD JEAN-LUC | Director | May 11, 2011 | Option Exercise | $34.25 | 1,896 | 64,938 | 26,272 | May 13, 2011, 05:23 PM |
| BELINGARD JEAN-LUC | Director | May 11, 2011 | Sale | $98.79 | 1,896 | 187,298 | 25,172 | May 13, 2011, 05:23 PM |
| BELINGARD JEAN-LUC | Director | May 09, 2011 | Option Exercise | $98.48 | 30 | 2,954 | 24,376 | May 10, 2011, 03:35 PM |
| BELINGARD JEAN-LUC | Director | May 06, 2011 | Option Exercise | $97.59 | 37 | 3,611 | 24,406 | May 10, 2011, 03:35 PM |
| LANE WENDY E | Director | Apr 25, 2011 | Option Exercise | $96.10 | 339 | 32,579 | 13,453 | Apr 27, 2011, 04:04 PM |
| LANE WENDY E | Director | Apr 25, 2011 | Option Exercise | $34.25 | 948 | 32,469 | 13,792 | Apr 27, 2011, 04:04 PM |
| KING DAVID P | President & CEO | Apr 25, 2011 | Sale | $95.86 | 7,254 | 695,368 | 101,765 | Apr 27, 2011, 04:03 PM |
| Brecher Mark E | Chief Medical Officer | Apr 21, 2011 | Sale | $98.00 | 1,271 | 124,558 | 5,828 | Apr 22, 2011, 11:23 AM |
| MAC MAHON THOMAS P | Director | Apr 15, 2011 | Option Exercise | $58.57 | 103,867 | 6,083,490 | 208,664 | Apr 18, 2011, 03:10 PM |
| MAC MAHON THOMAS P | Director | Apr 14, 2011 | Option Exercise | $58.57 | 71,133 | 4,166,260 | 175,930 | Apr 18, 2011, 03:10 PM |
| MAC MAHON THOMAS P | Director | Apr 14, 2011 | Sale | $95.00 | 71,133 | 6,757,855 | 104,797 | Apr 18, 2011, 03:10 PM |
| MAC MAHON THOMAS P | Director | Apr 15, 2011 | Sale | $95.97 | 83,867 | 8,048,482 | 130,797 | Apr 18, 2011, 03:10 PM |
| Walton Andrew Scott | EVP | Apr 14, 2011 | Sale | $95.00 | 1,535 | 145,825 | 18,413 | Apr 18, 2011, 03:08 PM |
| Walton Andrew Scott | EVP | Apr 11, 2011 | Sale | $92.69 | 1,536 | 142,372 | 19,948 | Apr 13, 2011, 02:50 PM |
| Walton Andrew Scott | EVP | Mar 30, 2011 | Option Exercise | $91.57 | 1,780 | 162,995 | 21,484 | Apr 01, 2011, 05:14 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Mar 30, 2011 | Option Exercise | $91.57 | 780 | 71,425 | 17,622 | Apr 01, 2011, 05:13 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Mar 30, 2011 | Option Exercise | $91.57 | 597 | 54,667 | 17,542 | Apr 01, 2011, 05:12 PM |
| Fonseca Lidia | Chief Information Officer | Mar 30, 2011 | Option Exercise | $91.57 | 597 | 54,667 | 5,325 | Apr 01, 2011, 05:11 PM |
| KING DAVID P | President & CEO | Mar 30, 2011 | Option Exercise | $91.57 | 10,702 | 979,982 | 109,019 | Apr 01, 2011, 05:09 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 30, 2011 | Option Exercise | $91.57 | 3,963 | 362,892 | 29,116 | Apr 01, 2011, 05:08 PM |
| Hayes William B | Chief Financial Officer, EVP | Mar 31, 2011 | Sale | $91.21 | 5,371 | 489,866 | 23,745 | Apr 01, 2011, 05:08 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 14, 2011 | Option Exercise | $87.73 | 141 | 12,370 | 16,302 | Feb 16, 2011, 03:33 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 14, 2011 | Option Exercise | $87.73 | 892 | 78,255 | 24,953 | Feb 16, 2011, 03:30 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 15, 2011 | Sale | $87.45 | 1,208 | 105,640 | 23,745 | Feb 16, 2011, 03:30 PM |
| Walton Andrew Scott | EVP | Feb 14, 2011 | Option Exercise | $87.73 | 357 | 31,320 | 18,413 | Feb 16, 2011, 03:27 PM |
| KING DAVID P | President & CEO | Feb 14, 2011 | Option Exercise | $87.73 | 2,435 | 213,623 | 94,511 | Feb 16, 2011, 03:23 PM |
| Fonseca Lidia | Chief Information Officer | Feb 14, 2011 | Option Exercise | $87.73 | 141 | 12,370 | 4,085 | Feb 16, 2011, 03:19 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 14, 2011 | Option Exercise | $87.73 | 141 | 12,370 | 16,565 | Feb 16, 2011, 03:18 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 11, 2011 | Sale | $87.18 | 1,846 | 160,934 | 25,845 | Feb 15, 2011, 12:08 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 10, 2011 | Option Exercise | $87.73 | 887 | 77,817 | 58,058 | Feb 11, 2011, 05:46 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 09, 2011 | Option Exercise | $90.74 | 718 | 65,151 | 24,726 | Feb 11, 2011, 05:46 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 10, 2011 | Option Exercise | $60.04 | 30,367 | 1,823,235 | 58,945 | Feb 11, 2011, 05:46 PM |
| Hayes William B | Chief Financial Officer, EVP | Feb 10, 2011 | Sale | $88.18 | 31,815 | 2,805,425 | 30,591 | Feb 11, 2011, 05:46 PM |
| KING DAVID P | President & CEO | Feb 10, 2011 | Option Exercise | $87.73 | 2,692 | 236,169 | 96,946 | Feb 11, 2011, 05:16 PM |
| KING DAVID P | President & CEO | Feb 09, 2011 | Option Exercise | $90.74 | 2,077 | 188,467 | 82,938 | Feb 11, 2011, 05:16 PM |
| Conrad Andrew J | EVP, Chief Scientific Officer | Feb 10, 2011 | Option Exercise | $87.73 | 514 | 45,093 | 26,541 | Feb 11, 2011, 05:13 PM |
| Conrad Andrew J | EVP, Chief Scientific Officer | Feb 09, 2011 | Option Exercise | $90.74 | 496 | 45,007 | 27,055 | Feb 11, 2011, 05:13 PM |
| Brecher Mark E | Chief Medical Officer | Feb 10, 2011 | Option Exercise | $87.73 | 184 | 16,142 | 6,749 | Feb 11, 2011, 04:40 PM |
| Brecher Mark E | Chief Medical Officer | Feb 09, 2011 | Option Exercise | $90.74 | 1,075 | 97,545 | 2,624 | Feb 11, 2011, 04:40 PM |
| Walton Andrew Scott | EVP | Feb 09, 2011 | Option Exercise | $90.74 | 412 | 37,385 | 16,336 | Feb 11, 2011, 04:40 PM |
| Walton Andrew Scott | EVP | Feb 10, 2011 | Option Exercise | $87.73 | 466 | 40,882 | 18,770 | Feb 11, 2011, 04:40 PM |
| Fonseca Lidia | Chief Information Officer | Feb 10, 2011 | Option Exercise | $87.73 | 178 | 15,616 | 4,226 | Feb 11, 2011, 04:36 PM |
| Fonseca Lidia | Chief Information Officer | Feb 09, 2011 | Option Exercise | $90.74 | 171 | 15,517 | 3,304 | Feb 11, 2011, 04:36 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 09, 2011 | Option Exercise | $90.74 | 685 | 62,157 | 11,772 | Feb 11, 2011, 04:30 PM |
| Boyle James T. Jr. | EVP, Chief Operating Officer | Feb 10, 2011 | Option Exercise | $87.73 | 466 | 40,882 | 16,706 | Feb 11, 2011, 04:30 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 10, 2011 | Option Exercise | $87.73 | 178 | 15,616 | 16,443 | Feb 11, 2011, 04:28 PM |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | Feb 09, 2011 | Option Exercise | $90.74 | 171 | 15,517 | 15,521 | Feb 11, 2011, 04:28 PM |
| Hayes William B | Chief Financial Officer, EVP | Dec 27, 2010 | Option Exercise | $60.04 | 30,366 | 1,823,175 | 55,810 | Dec 28, 2010, 02:04 PM |
| Hayes William B | Chief Financial Officer, EVP | Dec 27, 2010 | Sale | $87.95 | 30,366 | 2,670,702 | 25,444 | Dec 28, 2010, 02:04 PM |
| MAC MAHON THOMAS P | Director | Dec 01, 2010 | Option Exercise | $47.89 | 175,000 | 8,380,750 | 259,797 | Dec 03, 2010, 09:21 AM |
| MAC MAHON THOMAS P | Director | Dec 01, 2010 | Sale | $85.00 | 155,000 | 13,175,000 | 104,797 | Dec 03, 2010, 09:21 AM |
| Walton Andrew Scott | EVP | Oct 29, 2010 | Sale | $81.00 | 881 | 71,361 | 16,748 | Nov 02, 2010, 05:16 PM |
| Walton Andrew Scott | EVP | Oct 29, 2010 | Sale | $81.00 | 881 | 71,361 | 16,748 | Nov 02, 2010, 05:16 PM |
| Walton Andrew Scott | EVP | Oct 29, 2010 | Sale | $81.00 | 881 | 71,361 | 16,748 | Nov 02, 2010, 08:27 AM |
| Walton Andrew Scott | EVP | Oct 29, 2010 | Sale | $81.00 | 881 | 71,361 | 16,748 | Nov 02, 2010, 08:27 AM |
| Hayes William B | Chief Financial Officer, EVP | Oct 13, 2010 | Option Exercise | $58.57 | 30,000 | 1,757,100 | 55,444 | Oct 15, 2010, 02:45 PM |
| Hayes William B | Chief Financial Officer, EVP | Oct 13, 2010 | Sale | $80.00 | 30,000 | 2,400,000 | 25,444 | Oct 15, 2010, 02:45 PM |
| Walton Andrew Scott | EVP | Oct 06, 2010 | Option Exercise | $58.57 | 5,000 | 292,850 | 22,629 | Oct 08, 2010, 04:15 PM |
| Walton Andrew Scott | EVP | Oct 06, 2010 | Sale | $79.50 | 5,000 | 397,500 | 17,629 | Oct 08, 2010, 04:15 PM |
| Walton Andrew Scott | EVP | Oct 01, 2010 | Sale | $79.00 | 881 | 69,599 | 17,629 | Oct 05, 2010, 04:54 PM |
| Walton Andrew Scott | EVP | Oct 01, 2010 | Sale | $79.00 | 881 | 69,599 | 17,629 | Oct 05, 2010, 04:54 PM |
| MITTELSTAEDT ROBERT E JR | Director | Sep 08, 2010 | Option Exercise | $34.25 | 1,896 | 64,938 | 13,304 | Sep 10, 2010, 10:31 AM |
| MITTELSTAEDT ROBERT E JR | Director | Sep 08, 2010 | Sale | $74.32 | 1,896 | 140,906 | 13,204 | Sep 10, 2010, 10:31 AM |
| Conrad Andrew J | EVP, Chief Scientific Officer | Jul 26, 2010 | Buy | $74.32 | 6,100 | 453,347 | 6,100 | Jul 30, 2010, 11:07 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Kirchgraber Paul R | CEO, Covance Drug Development | 05/19/2023 | 784,793 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 05/19/2023 | 932,707 |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | 05/18/2023 | 195,900 |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | 05/18/2023 | 325,155 |
| Schechter Adam H | President & CEO | 03/30/2023 | 4,189,756 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 03/30/2023 | 648,484 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/30/2023 | 1,163,721 |
| Caveney Brian J | EVP, President of Diagnostics | 03/30/2023 | 671,853 |
| BERBERIAN LANCE | EVP, CIO & CTO | 03/30/2023 | 404,235 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 03/30/2023 | 643,990 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 03/31/2023 | 879,982 |
| Seltz Judith C | EVP, CHRO | 03/30/2023 | 261,551 |
| Summy Amy B. | EVP, Chief Marketing Officer | 03/30/2023 | 285,144 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 03/30/2023 | 308,064 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 03/30/2023 | 118,192 |
| Summy Amy B. | EVP, Chief Marketing Officer | 03/02/2023 | 89,558 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/21/2023 | 547,530 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/21/2023 | 2,004,675 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/14/2023 | 76,518 |
| BELINGARD JEAN-LUC | Director | 02/13/2023 | 18,610 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/13/2023 | 21,091 |
| Caveney Brian J | EVP, President of Diagnostics | 02/13/2023 | 30,768 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/13/2023 | 35,234 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/13/2023 | 48,385 |
| Schechter Adam H | President & CEO | 02/13/2023 | 290,312 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/13/2023 | 28,287 |
| Seltz Judith C | EVP, CHRO | 02/13/2023 | 17,121 |
| Summy Amy B. | EVP, Chief Marketing Officer | 02/13/2023 | 13,399 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/13/2023 | 19,354 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/13/2023 | 9,429 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/07/2023 | 53,219 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/07/2023 | 99,391 |
| Schechter Adam H | President & CEO | 02/06/2023 | 334,476 |
| Caveney Brian J | EVP, President of Diagnostics | 02/06/2023 | 40,098 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/06/2023 | 26,406 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/06/2023 | 63,815 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/06/2023 | 40,098 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/06/2023 | 36,920 |
| Seltz Judith C | EVP, CHRO | 02/06/2023 | 20,538 |
| Summy Amy B. | EVP, Chief Marketing Officer | 02/06/2023 | 20,294 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/06/2023 | 19,805 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/06/2023 | 12,714 |
| Seltz Judith C | EVP, CHRO | 02/02/2023 | 19,634 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/02/2023 | 16,319 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/03/2023 | 43,925 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/02/2023 | 10,455 |
| Summy Amy B. | EVP, Chief Marketing Officer | 02/02/2023 | 19,634 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/02/2023 | 30,344 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/03/2023 | 82,264 |
| Schechter Adam H | President & CEO | 02/02/2023 | 205,267 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/02/2023 | 35,954 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/02/2023 | 52,528 |
| Caveney Brian J | EVP, President of Diagnostics | 02/02/2023 | 36,719 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/02/2023 | 26,009 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 11/08/2022 | 259,660 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 11/07/2022 | 208,990 |
| Caveney Brian J | EVP, President of Diagnostics | 11/07/2022 | 208,990 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 11/01/2022 | 1,190,251 |
| Schechter Adam H | President & CEO | 11/01/2022 | 198,746 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 11/01/2022 | 198,524 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 09/26/2022 | 5,265,581 |
| Caveney Brian J | EVP, President of Diagnostics | 09/07/2022 | 10,173 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 08/03/2022 | 4,722,543 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 08/03/2022 | 8,151,450 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 08/01/2022 | 5,933 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 08/01/2022 | 112,435 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 08/01/2022 | 665,634 |
| Caveney Brian J | EVP, President of Diagnostics | 06/07/2022 | 10,172 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 03/29/2022 | 652,871 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 03/29/2022 | 678,642 |
| BERBERIAN LANCE | EVP, CIO & CTO | 03/28/2022 | 652,351 |
| Caveney Brian J | EVP, President of Diagnostics | 03/28/2022 | 520,499 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/28/2022 | 1,737,576 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 03/28/2022 | 455,540 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 03/28/2022 | 521,052 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 03/28/2022 | 495,345 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 03/28/2022 | 252,924 |
| Williams R Sanders | Director | 03/25/2022 | 156,145 |
| Summy Amy B. | EVP, Chief Marketing Officer | 03/10/2022 | 65,290 |
| NEUPERT PETER M | Director | 02/16/2022 | 922,815 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/15/2022 | 56,714 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/15/2022 | 56,714 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/14/2022 | 71,169 |
| Caveney Brian J | EVP, President of Diagnostics | 02/14/2022 | 212,145 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/14/2022 | 75,532 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/14/2022 | 29,449 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/14/2022 | 217,871 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/14/2022 | 20,996 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/14/2022 | 20,996 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/04/2022 | 30,245 |
| Caveney Brian J | EVP, President of Diagnostics | 02/04/2022 | 45,784 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/04/2022 | 79,359 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/04/2022 | 45,784 |
| Schechter Adam H | President & CEO | 02/04/2022 | 391,802 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/04/2022 | 42,177 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/07/2022 | 56,586 |
| Seltz Judith C | EVP, CHRO | 02/04/2022 | 23,586 |
| Summy Amy B. | EVP, Chief Marketing Officer | 02/04/2022 | 23,031 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/04/2022 | 22,753 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/07/2022 | 60,469 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/04/2022 | 14,706 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/02/2022 | 33,055 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/03/2022 | 43,761 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/02/2022 | 17,484 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/03/2022 | 46,751 |
| Summy Amy B. | EVP, Chief Marketing Officer | 02/02/2022 | 21,035 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/02/2022 | 39,338 |
| Seltz Judith C | EVP, CHRO | 02/02/2022 | 20,762 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/02/2022 | 11,200 |
| Caveney Brian J | EVP, President of Diagnostics | 02/02/2022 | 40,157 |
| Schechter Adam H | President & CEO | 02/02/2022 | 219,364 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/02/2022 | 64,470 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/02/2022 | 28,138 |
| BELINGARD JEAN-LUC | Director | 02/02/2022 | 21,308 |
| Gilliland Dwight Gary | Director | 12/15/2021 | 151,128 |
| Caveney Brian J | EVP, President of Diagnostics | 11/05/2021 | 247,081 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 11/05/2021 | 247,081 |
| Schechter Adam H | President & CEO | 11/01/2021 | 255,859 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 11/01/2021 | 1,164,939 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 11/01/2021 | 259,324 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 09/15/2021 | 381,870 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 09/15/2021 | 1,335,510 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 08/02/2021 | 4,464 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 06/07/2021 | 381,870 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 06/07/2021 | 1,199,520 |
| BELINGARD JEAN-LUC | Director | 05/03/2021 | 256,074 |
| BELINGARD JEAN-LUC | Director | 05/03/2021 | 699,803 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 04/03/2021 | 114,207 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 03/30/2021 | 168,004 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 03/30/2021 | 204,527 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/27/2021 | 904,430 |
| BERBERIAN LANCE | EVP, CIO & CTO | 03/27/2021 | 271,455 |
| Caveney Brian J | EVP, President of Diagnostics | 03/27/2021 | 271,455 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 03/27/2021 | 198,748 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 03/27/2021 | 271,455 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 03/27/2021 | 172,835 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/12/2021 | 62,662 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/18/2021 | 340,251 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/18/2021 | 559,590 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/12/2021 | 37,645 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/16/2021 | 49,202 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/12/2021 | 33,833 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/16/2021 | 44,567 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/12/2021 | 42,887 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/12/2021 | 121,989 |
| Caveney Brian J | EVP, President of Diagnostics | 02/12/2021 | 203,474 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/12/2021 | 208,001 |
| Schechter Adam H | President & CEO | 02/04/2021 | 230,046 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/04/2021 | 11,860 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/04/2021 | 18,574 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 02/05/2021 | 24,618 |
| Summy Amy B. | EVP, Chief Marketing Officer | 02/04/2021 | 21,035 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/04/2021 | 34,462 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/05/2021 | 45,848 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/04/2021 | 41,847 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/04/2021 | 68,477 |
| Caveney Brian J | EVP, President of Diagnostics | 02/04/2021 | 42,518 |
| BERBERIAN LANCE | EVP, CIO & CTO | 02/04/2021 | 29,315 |
| Seltz Judith C | EVP, CHRO | 02/04/2021 | 21,483 |
| BELINGARD JEAN-LUC | Director | 02/04/2021 | 22,154 |
| Williams R Sanders | Director | 01/26/2021 | 128,037 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 11/06/2020 | 126,179 |
| Caveney Brian J | EVP, President of Diagnostics | 11/05/2020 | 189,976 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 11/05/2020 | 179,041 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 11/04/2020 | 321,204 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 11/02/2020 | 835,966 |
| Schechter Adam H | President & CEO | 11/02/2020 | 183,399 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 11/02/2020 | 185,471 |
| Caveney Brian J | EVP, President of Diagnostics | 09/25/2020 | 52,306 |
| Williams R Sanders | Director | 07/08/2020 | 128,037 |
| Williams R Sanders | Director | 07/08/2020 | 225,056 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 07/02/2020 | 73,950 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 06/24/2020 | 139,808 |
| KING DAVID P | Director | 05/05/2020 | 5,000,000 |
| Seltz Judith C | EVP, CHRO | 03/10/2020 | 55,625 |
| Seltz Judith C | EVP, CHRO | 02/28/2020 | 43,735 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 04/03/2020 | 42,151 |
| KING DAVID P | Director | 03/30/2020 | 3,243,727 |
| van der Vaart Sandra D | EVP, Chief Legal Officer | 03/30/2020 | 145,937 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/30/2020 | 763,595 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 03/30/2020 | 133,797 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 03/30/2020 | 152,138 |
| BERBERIAN LANCE | EVP, CIO & CTO | 03/30/2020 | 223,655 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/21/2020 | 56,326 |
| BELINGARD JEAN-LUC | Director | 02/19/2020 | 239,289 |
| BELINGARD JEAN-LUC | Director | 02/19/2020 | 5,024,761 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/12/2020 | 96,005 |
| van der Vaart Sandra D | SVP, Global General Counsel | 02/12/2020 | 29,627 |
| van der Vaart Sandra D | SVP, Global General Counsel | 02/13/2020 | 39,206 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/12/2020 | 26,626 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/13/2020 | 35,436 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/12/2020 | 163,509 |
| Caveney Brian J | EVP, President of Diagnostics | 02/12/2020 | 162,384 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 02/12/2020 | 51,003 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/12/2020 | 29,814 |
| KING DAVID P | Director | 02/12/2020 | 615,033 |
| BELINGARD JEAN-LUC | Director | 02/12/2020 | 23,064 |
| Williams R Sanders | Director | 02/13/2020 | 231,277 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/07/2020 | 14,951 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 02/10/2020 | 19,655 |
| van der Vaart Sandra D | SVP, Global General Counsel | 02/07/2020 | 18,415 |
| van der Vaart Sandra D | SVP, Global General Counsel | 02/10/2020 | 24,205 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 02/07/2020 | 18,780 |
| KING DAVID P | Director | 02/07/2020 | 228,277 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/07/2020 | 53,787 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/07/2020 | 18,780 |
| BELINGARD JEAN-LUC | Director | 12/04/2019 | 56,185 |
| KING DAVID P | President & CEO | 10/28/2019 | 4,991,216 |
| ANDERSON KERRII B | Director | 09/23/2019 | 256,074 |
| ANDERSON KERRII B | Director | 09/23/2019 | 446,810 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 09/04/2019 | 322,060 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 09/04/2019 | 415,743 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 08/30/2019 | 1,002,171 |
| Williams R Sanders | Director | 08/05/2019 | 81,455 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 07/08/2019 | 983,260 |
| van der Vaart Sandra D | SVP, Global General Counsel | 07/08/2019 | 411,474 |
| ANDERSON KERRII B | Director | 06/20/2019 | 239,289 |
| ANDERSON KERRII B | Director | 06/20/2019 | 527,000 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 06/07/2019 | 1,673,971 |
| Williams R Sanders | Director | 05/06/2019 | 81,100 |
| MITTELSTAEDT ROBERT E JR | Director | 05/03/2019 | 238,354 |
| MITTELSTAEDT ROBERT E JR | Director | 05/03/2019 | 615,310 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 05/02/2019 | 656,000 |
| Ratliff John D | CEO, Covance Drug Development | 04/03/2019 | 169,841 |
| KING DAVID P | President & CEO | 04/01/2019 | 6,394,529 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 04/01/2019 | 1,549,912 |
| van der Vaart Sandra D | SVP, Global General Counsel | 04/01/2019 | 275,836 |
| Dodson Edward T | Principal Accounting Officer | 04/01/2019 | 275,371 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 04/01/2019 | 500,900 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 04/01/2019 | 354,005 |
| BELINGARD JEAN-LUC | Director | 02/12/2019 | 15,245 |
| BELINGARD JEAN-LUC | Director | 02/12/2019 | 238,354 |
| BELINGARD JEAN-LUC | Director | 02/12/2019 | 540,407 |
| KING DAVID P | President & CEO | 02/12/2019 | 230,293 |
| Williams R Sanders | Director | 02/13/2019 | 152,586 |
| Dodson Edward T | Principal Accounting Officer | 02/12/2019 | 7,916 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/12/2019 | 9,382 |
| Ratliff John D | CEO, Covance Drug Development | 02/12/2019 | 95,870 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/12/2019 | 34,009 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/12/2019 | 10,261 |
| Caveney Brian J | SVP, Chief Medical Officer | 02/12/2019 | 12,020 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 02/12/2019 | 15,099 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 02/11/2019 | 34,630 |
| Dodson Edward T | Principal Accounting Officer | 02/11/2019 | 17,892 |
| KING DAVID P | President & CEO | 02/11/2019 | 429,984 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/11/2019 | 20,633 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/11/2019 | 209,076 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/11/2019 | 149,629 |
| Ratliff John D | CEO, Covance Drug Development | 02/11/2019 | 284,684 |
| Ratliff John D | CEO, Covance Drug Development | 02/07/2019 | 81,988 |
| KING DAVID P | President & CEO | 02/07/2019 | 184,915 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/07/2019 | 43,796 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/07/2019 | 12,092 |
| Dodson Edward T | Principal Accounting Officer | 02/07/2019 | 10,027 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 02/07/2019 | 21,824 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/07/2019 | 15,336 |
| Williams R Sanders | Director | 11/27/2018 | 56,749 |
| ANDERSON KERRII B | Director | 11/05/2018 | 238,354 |
| ANDERSON KERRII B | Director | 11/05/2018 | 604,162 |
| Gary M. Huff | CEO, LabCorp Diagnostics | 09/04/2018 | 11,671 |
| Dodson Edward T | Principal Accounting Officer | 06/06/2018 | 1,103,180 |
| Dodson Edward T | Principal Accounting Officer | 06/06/2018 | 2,383,563 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 06/04/2018 | 819,450 |
| Gilliland Dwight Gary | Director | 05/31/2018 | 228,967 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 05/31/2018 | 1,002,672 |
| Gary M. Huff | CEO, LabCorp Diagnostics | 05/30/2018 | 293,823 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 05/30/2018 | 1,812,067 |
| KING DAVID P | President & CEO | 05/23/2018 | 4,240,115 |
| KING DAVID P | President & CEO | 05/23/2018 | 8,762,352 |
| KING DAVID P | President & CEO | 04/23/2018 | 4,240,200 |
| KING DAVID P | President & CEO | 04/23/2018 | 8,300,692 |
| Gary M. Huff | CEO, LabCorp Diagnostics | 04/04/2018 | 225,444 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 03/29/2018 | 343,072 |
| Dodson Edward T | Principal Accounting Officer | 03/29/2018 | 258,800 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/29/2018 | 348,086 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/29/2018 | 1,431,488 |
| KING DAVID P | President & CEO | 03/29/2018 | 5,340,176 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 03/29/2018 | 457,429 |
| KING DAVID P | President & CEO | 03/23/2018 | 4,240,200 |
| KING DAVID P | President & CEO | 03/23/2018 | 8,232,224 |
| Dodson Edward T | Principal Accounting Officer | 03/12/2018 | 19,493 |
| KING DAVID P | President & CEO | 03/12/2018 | 479,767 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/12/2018 | 22,654 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/12/2018 | 128,547 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 03/12/2018 | 21,073 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 03/12/2018 | 32,312 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/12/2018 | 1,405,839 |
| Ratliff John D | CEO, Covance Drug Development | 02/09/2018 | 358,347 |
| ANDERSON KERRII B | Director | 02/09/2018 | 249,579 |
| ANDERSON KERRII B | Director | 02/09/2018 | 548,123 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/09/2018 | 245,733 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/09/2018 | 176,148 |
| Dodson Edward T | Principal Accounting Officer | 02/09/2018 | 28,069 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/09/2018 | 24,204 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 02/09/2018 | 34,120 |
| KING DAVID P | President & CEO | 02/09/2018 | 527,435 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 02/07/2018 | 21,886 |
| KING DAVID P | President & CEO | 02/07/2018 | 214,450 |
| Ratliff John D | CEO, Covance Drug Development | 02/07/2018 | 95,010 |
| Gary M. Huff | CEO, LabCorp Diagnostics | 02/07/2018 | 55,818 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/07/2018 | 50,728 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/07/2018 | 13,912 |
| Dodson Edward T | Principal Accounting Officer | 02/07/2018 | 15,609 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/07/2018 | 17,814 |
| Schechter Adam H | Director | 02/08/2018 | 213,813 |
| BELINGARD JEAN-LUC | Director | 02/07/2018 | 21,547 |
| Gilliland Dwight Gary | Director | 10/30/2017 | 149,068 |
| Gary M. Huff | CEO, LabCorp Diagnostics | 09/01/2017 | 8,038 |
| KING DAVID P | President & CEO | 09/06/2017 | 4,054,898 |
| KING DAVID P | President & CEO | 09/06/2017 | 7,009,789 |
| KING DAVID P | President & CEO | 09/05/2017 | 12,042,377 |
| KING DAVID P | President & CEO | 09/05/2017 | 20,843,373 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 08/25/2017 | 2,177,239 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 08/25/2017 | 4,889,461 |
| Williams R Sanders | Director | 08/11/2017 | 239,289 |
| Williams R Sanders | Director | 08/11/2017 | 486,338 |
| Dodson Edward T | Principal Accounting Officer | 08/01/2017 | 459,740 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 08/01/2017 | 800,000 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 08/01/2017 | 951,669 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 06/16/2017 | 271,123 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 05/22/2017 | 505,260 |
| BELINGARD JEAN-LUC | Director | 05/09/2017 | 76,959 |
| BELINGARD JEAN-LUC | Director | 05/09/2017 | 141,052 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 03/29/2017 | 449,903 |
| Dodson Edward T | Principal Accounting Officer | 03/29/2017 | 408,092 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/29/2017 | 459,926 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/29/2017 | 1,396,532 |
| KING DAVID P | President & CEO | 03/29/2017 | 6,958,461 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 03/13/2017 | 527,053 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 03/13/2017 | 19,040 |
| Dodson Edward T | Principal Accounting Officer | 03/13/2017 | 21,492 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/13/2017 | 22,069 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/13/2017 | 111,642 |
| KING DAVID P | President & CEO | 03/13/2017 | 416,854 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/09/2017 | 327,691 |
| MITTELSTAEDT ROBERT E JR | Director | 02/24/2017 | 400,839 |
| MITTELSTAEDT ROBERT E JR | Director | 02/24/2017 | 756,256 |
| ANDERSON KERRII B | Director | 02/23/2017 | 152,589 |
| ANDERSON KERRII B | Director | 02/24/2017 | 75,630 |
| ANDERSON KERRII B | Director | 02/23/2017 | 278,880 |
| Dodson Edward T | Principal Accounting Officer | 02/13/2017 | 24,557 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/13/2017 | 27,796 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/13/2017 | 74,481 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/13/2017 | 65,981 |
| KING DAVID P | President & CEO | 02/13/2017 | 535,402 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/13/2017 | 65,981 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 02/09/2017 | 32,655 |
| Dodson Edward T | Principal Accounting Officer | 02/09/2017 | 18,469 |
| Ratliff John D | CEO, Covance Drug Development | 02/09/2017 | 269,400 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/09/2017 | 25,160 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/09/2017 | 215,466 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/09/2017 | 156,715 |
| KING DAVID P | President & CEO | 02/09/2017 | 334,040 |
| BELINGARD JEAN-LUC | Director | 02/09/2017 | 20,877 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 08/09/2016 | 164,780 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 08/04/2016 | 1,120,804 |
| MITTELSTAEDT ROBERT E JR | Director | 08/04/2016 | 76,959 |
| MITTELSTAEDT ROBERT E JR | Director | 08/04/2016 | 139,027 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 06/16/2016 | 246,550 |
| KING DAVID P | President & CEO | 06/13/2016 | 13,777,460 |
| KING DAVID P | President & CEO | 06/13/2016 | 25,139,088 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 04/29/2016 | 468,136 |
| Dodson Edward T | Principal Accounting Officer | 04/27/2016 | 1,187,337 |
| KING DAVID P | President & CEO | 03/30/2016 | 5,706,886 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/30/2016 | 707,925 |
| Dodson Edward T | Principal Accounting Officer | 03/30/2016 | 276,830 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/30/2016 | 290,618 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/31/2016 | 492,990 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 03/30/2016 | 1,956,899 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 03/31/2016 | 2,118,030 |
| BELINGARD JEAN-LUC | Director | 03/11/2016 | 14,321 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 03/11/2016 | 15,360 |
| Dodson Edward T | Principal Accounting Officer | 03/11/2016 | 14,321 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 03/11/2016 | 89,851 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/11/2016 | 17,785 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/14/2016 | 35,634 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 03/11/2016 | 163,187 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 03/14/2016 | 177,939 |
| KING DAVID P | President & CEO | 03/11/2016 | 335,498 |
| Keller Deborah L | CEO, Covance Drug Development | 03/11/2016 | 529,753 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 03/11/2016 | 390,241 |
| BELINGARD JEAN-LUC | Director | 02/25/2016 | 76,944 |
| BELINGARD JEAN-LUC | Director | 02/25/2016 | 142,225 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 02/16/2016 | 417,746 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/16/2016 | 38,117 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 02/12/2016 | 217,990 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 02/11/2016 | 136,383 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 02/12/2016 | 275,729 |
| KING DAVID P | President & CEO | 02/11/2016 | 280,675 |
| KING DAVID P | President & CEO | 02/12/2016 | 384,780 |
| Dodson Edward T | Principal Accounting Officer | 02/12/2016 | 18,750 |
| Dodson Edward T | Principal Accounting Officer | 02/11/2016 | 21,497 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/12/2016 | 52,746 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/11/2016 | 56,277 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 02/11/2016 | 52,018 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/12/2016 | 18,235 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/11/2016 | 23,119 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/12/2016 | 41,176 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 01/08/2016 | 144,646 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 12/08/2015 | 124,543 |
| Williams R Sanders | Director | 11/02/2015 | 119,177 |
| Williams R Sanders | Director | 11/02/2015 | 229,949 |
| ANDERSON KERRII B | Director | 10/29/2015 | 76,944 |
| KING DAVID P | President & CEO | 08/03/2015 | 4,018,500 |
| KING DAVID P | President & CEO | 08/03/2015 | 6,396,358 |
| HERRING JOSEPH L | CEO of Covance Drug Division | 07/31/2015 | 1,220,202 |
| KING DAVID P | President & CEO | 07/01/2015 | 4,018,500 |
| KING DAVID P | President & CEO | 07/01/2015 | 6,089,040 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 06/16/2015 | 192,286 |
| KING DAVID P | President & CEO | 06/01/2015 | 4,018,500 |
| KING DAVID P | President & CEO | 06/01/2015 | 5,928,845 |
| MITTELSTAEDT ROBERT E JR | Director | 05/19/2015 | 76,944 |
| MITTELSTAEDT ROBERT E JR | Director | 05/19/2015 | 154,254 |
| Williams R Sanders | Director | 05/11/2015 | 113,914 |
| BELINGARD JEAN-LUC | Director | 04/29/2015 | 76,992 |
| BELINGARD JEAN-LUC | Director | 04/29/2015 | 189,820 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 04/23/2015 | 176,425 |
| Brecher Mark E | CMO, LabCorp Diagnostics | 03/30/2015 | 21,892 |
| Brecher Mark E | CMO, LabCorp Diagnostics | 03/30/2015 | 1,697,520 |
| Brecher Mark E | CMO, LabCorp Diagnostics | 03/31/2015 | 44,069 |
| Brecher Mark E | CMO, LabCorp Diagnostics | 03/30/2015 | 2,574,921 |
| KING DAVID P | President & CEO | 03/30/2015 | 505,811 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 03/30/2015 | 161,900 |
| Dodson Edward T | Principal Accounting Officer | 03/30/2015 | 21,892 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/30/2015 | 21,892 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/02/2015 | 139,397 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/03/2015 | 153,015 |
| Dodson Edward T | Principal Accounting Officer | 03/02/2015 | 18,997 |
| Brecher Mark E | Chief Medical Officer | 03/02/2015 | 18,997 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/02/2015 | 19,121 |
| KING DAVID P | President & CEO | 03/02/2015 | 433,610 |
| Williams R Sanders | Director | 02/26/2015 | 281,025 |
| HERRING JOSEPH L | CEO of Covance Drug Division | 02/25/2015 | 4,485,436 |
| Dodson Edward T | Principal Accounting Officer | 02/12/2015 | 20,798 |
| KING DAVID P | President & CEO | 02/12/2015 | 460,934 |
| Brecher Mark E | Chief Medical Officer | 02/12/2015 | 20,681 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/12/2015 | 20,798 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/12/2015 | 59,588 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/12/2015 | 267,213 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/13/2015 | 452,991 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/12/2015 | 316,751 |
| Dodson Edward T | Principal Accounting Officer | 02/11/2015 | 24,747 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/11/2015 | 156,652 |
| Brecher Mark E | Chief Medical Officer | 02/11/2015 | 24,863 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/11/2015 | 26,614 |
| EISENBERG GLENN A | Chief Financial Officer, EVP | 02/11/2015 | 64,785 |
| KING DAVID P | President & CEO | 02/11/2015 | 380,773 |
| BELINGARD JEAN-LUC | Director | 02/10/2015 | 17,424 |
| KING DAVID P | President & CEO | 09/22/2014 | 4,933,647 |
| KING DAVID P | President & CEO | 09/22/2014 | 6,830,741 |
| Williams R Sanders | Director | 09/05/2014 | 215,906 |
| KING DAVID P | President & CEO | 08/22/2014 | 4,933,572 |
| KING DAVID P | President & CEO | 08/22/2014 | 6,921,482 |
| KING DAVID P | President & CEO | 07/22/2014 | 4,933,572 |
| KING DAVID P | President & CEO | 07/22/2014 | 6,885,411 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 06/09/2014 | 3,275,596 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 06/09/2014 | 3,975,800 |
| Hayes William B | Chief Financial Officer, EVP | 06/06/2014 | 4,185,380 |
| Hayes William B | Chief Financial Officer, EVP | 06/06/2014 | 4,936,965 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 06/06/2014 | 600,400 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 06/06/2014 | 1,043,700 |
| Brecher Mark E | Chief Medical Officer | 06/04/2014 | 266,006 |
| Williams R Sanders | Director | 05/08/2014 | 157,643 |
| Rubenstein Arthur H | Director | 05/08/2014 | 157,643 |
| Schechter Adam H | Director | 05/08/2014 | 157,643 |
| NEUPERT PETER M | Director | 05/08/2014 | 157,643 |
| MITTELSTAEDT ROBERT E JR | Director | 05/08/2014 | 157,643 |
| LANE WENDY E | Director | 05/08/2014 | 157,643 |
| BELINGARD JEAN-LUC | Director | 05/08/2014 | 15,834 |
| BELINGARD JEAN-LUC | Director | 05/08/2014 | 157,643 |
| ANDERSON KERRII B | Director | 05/08/2014 | 157,643 |
| WEIKEL M KEITH | Director | 05/07/2014 | 76,979 |
| WEIKEL M KEITH | Director | 05/08/2014 | 157,643 |
| WEIKEL M KEITH | Director | 05/07/2014 | 194,979 |
| BELINGARD JEAN-LUC | Director | 04/30/2014 | 76,979 |
| BELINGARD JEAN-LUC | Director | 04/30/2014 | 195,782 |
| Hayes William B | Chief Financial Officer, EVP | 04/30/2014 | 245,680 |
| LANE WENDY E | Director | 04/30/2014 | 38,490 |
| LANE WENDY E | Director | 04/30/2014 | 38,599 |
| MITTELSTAEDT ROBERT E JR | Director | 04/30/2014 | 153,971 |
| MITTELSTAEDT ROBERT E JR | Director | 04/30/2014 | 346,923 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/27/2014 | 225,492 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/28/2014 | 247,966 |
| Brecher Mark E | Chief Medical Officer | 03/27/2014 | 32,199 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/27/2014 | 32,199 |
| Hayes William B | Chief Financial Officer, EVP | 03/27/2014 | 223,437 |
| KING DAVID P | President & CEO | 03/27/2014 | 703,979 |
| Hayes William B | Chief Financial Officer, EVP | 03/07/2014 | 1,626,427 |
| Hayes William B | Chief Financial Officer, EVP | 03/07/2014 | 1,811,187 |
| Hayes William B | Chief Financial Officer, EVP | 03/06/2014 | 440,119 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/03/2014 | 147,221 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/28/2014 | 73,429 |
| Brecher Mark E | Chief Medical Officer | 02/28/2014 | 14,125 |
| Hayes William B | Chief Financial Officer, EVP | 02/28/2014 | 72,400 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/28/2014 | 14,125 |
| KING DAVID P | President & CEO | 02/28/2014 | 329,074 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/12/2014 | 186,145 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/13/2014 | 372,266 |
| KING DAVID P | President & CEO | 02/12/2014 | 359,280 |
| Brecher Mark E | Chief Medical Officer | 02/12/2014 | 17,650 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/12/2014 | 16,740 |
| Hayes William B | Chief Financial Officer, EVP | 02/12/2014 | 84,975 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/10/2014 | 12,972 |
| Brecher Mark E | Chief Medical Officer | 02/10/2014 | 12,972 |
| Hayes William B | Chief Financial Officer, EVP | 02/10/2014 | 54,810 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/10/2014 | 54,445 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/11/2014 | 109,745 |
| KING DAVID P | President & CEO | 02/10/2014 | 203,254 |
| KING DAVID P | President & CEO | 01/27/2014 | 1,452,968 |
| KING DAVID P | President & CEO | 01/27/2014 | 2,181,637 |
| KING DAVID P | President & CEO | 12/24/2013 | 1,501,000 |
| KING DAVID P | President & CEO | 12/24/2013 | 2,269,750 |
| Brecher Mark E | Chief Medical Officer | 11/25/2013 | 42,248 |
| KING DAVID P | President & CEO | 11/25/2013 | 1,501,000 |
| KING DAVID P | President & CEO | 11/25/2013 | 2,650,300 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 11/11/2013 | 585,700 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 11/11/2013 | 1,058,350 |
| KING DAVID P | President & CEO | 10/24/2013 | 1,501,000 |
| KING DAVID P | President & CEO | 10/24/2013 | 2,522,801 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 10/17/2013 | 1,892,772 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 10/17/2013 | 2,488,800 |
| KING DAVID P | President & CEO | 09/25/2013 | 1,501,000 |
| KING DAVID P | President & CEO | 09/25/2013 | 2,476,615 |
| KING DAVID P | President & CEO | 08/26/2013 | 1,501,000 |
| KING DAVID P | President & CEO | 08/26/2013 | 2,415,047 |
| MITTELSTAEDT ROBERT E JR | Director | 08/21/2013 | 719,592 |
| KING DAVID P | President & CEO | 07/24/2013 | 1,501,000 |
| KING DAVID P | President & CEO | 07/24/2013 | 2,442,897 |
| KING DAVID P | President & CEO | 06/24/2013 | 1,501,000 |
| KING DAVID P | President & CEO | 06/24/2013 | 2,466,533 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 06/07/2013 | 4,426,465 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 06/07/2013 | 6,286,653 |
| Brecher Mark E | Chief Medical Officer | 05/28/2013 | 1,045,235 |
| Brecher Mark E | Chief Medical Officer | 05/28/2013 | 1,705,548 |
| BELINGARD JEAN-LUC | Director | 05/24/2013 | 6,022 |
| Hayes William B | Chief Financial Officer, EVP | 05/21/2013 | 9,880,836 |
| Hayes William B | Chief Financial Officer, EVP | 05/21/2013 | 12,720,000 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 05/17/2013 | 478,900 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 05/17/2013 | 984,700 |
| BELINGARD JEAN-LUC | Director | 05/13/2013 | 5,131 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 05/10/2013 | 3,591,261 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 05/10/2013 | 6,464,866 |
| BELINGARD JEAN-LUC | Director | 05/08/2013 | 76,993 |
| BELINGARD JEAN-LUC | Director | 05/08/2013 | 235,544 |
| WEIKEL M KEITH | Director | 05/03/2013 | 64,142 |
| WEIKEL M KEITH | Director | 05/03/2013 | 190,086 |
| LANE WENDY E | Director | 04/29/2013 | 38,617 |
| LANE WENDY E | Director | 04/29/2013 | 38,496 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 04/25/2013 | 140,760 |
| Williams R Sanders | Director | 04/24/2013 | 119,177 |
| Williams R Sanders | Director | 04/24/2013 | 173,477 |
| Hayes William B | Chief Financial Officer, EVP | 04/11/2013 | 1,559,715 |
| Hayes William B | Chief Financial Officer, EVP | 04/11/2013 | 2,112,230 |
| KING DAVID P | President & CEO | 03/28/2013 | 1,549,636 |
| Fonseca Lidia | Chief Information Officer | 03/28/2013 | 78,654 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/28/2013 | 78,654 |
| Hayes William B | Chief Financial Officer, EVP | 03/28/2013 | 503,316 |
| Brecher Mark E | Chief Medical Officer | 03/28/2013 | 81,451 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/28/2013 | 494,657 |
| KING DAVID P | President & CEO | 02/28/2013 | 313,024 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/28/2013 | 69,994 |
| Hayes William B | Chief Financial Officer, EVP | 02/28/2013 | 69,019 |
| Brecher Mark E | Chief Medical Officer | 02/28/2013 | 13,822 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/28/2013 | 13,822 |
| Fonseca Lidia | Chief Information Officer | 02/28/2013 | 13,822 |
| KING DAVID P | President & CEO | 02/11/2013 | 370,597 |
| Brecher Mark E | Chief Medical Officer | 02/11/2013 | 28,999 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/11/2013 | 27,919 |
| Fonseca Lidia | Chief Information Officer | 02/11/2013 | 27,919 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/11/2013 | 116,898 |
| Hayes William B | Chief Financial Officer, EVP | 02/11/2013 | 119,329 |
| MAC MAHON THOMAS P | Director | 09/06/2012 | 3,141,044 |
| MITTELSTAEDT ROBERT E JR | Director | 08/27/2012 | 76,993 |
| MITTELSTAEDT ROBERT E JR | Director | 08/27/2012 | 224,715 |
| Brecher Mark E | Chief Medical Officer | 07/13/2012 | 1,152,768 |
| Brecher Mark E | Chief Medical Officer | 07/13/2012 | 1,932,395 |
| Fonseca Lidia | Chief Information Officer | 07/13/2012 | 1,092,728 |
| Fonseca Lidia | Chief Information Officer | 07/13/2012 | 1,729,000 |
| KING DAVID P | President & CEO | 07/09/2012 | 5,039,942 |
| KING DAVID P | President & CEO | 07/09/2012 | 7,810,928 |
| Fonseca Lidia | Chief Information Officer | 06/27/2012 | 151,830 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 06/04/2012 | 224,504 |
| BELINGARD JEAN-LUC | Director | 05/14/2012 | 2,560 |
| BELINGARD JEAN-LUC | Director | 05/11/2012 | 2,081 |
| LANE WENDY E | Director | 05/09/2012 | 32,510 |
| LANE WENDY E | Director | 05/09/2012 | 43,851 |
| LANE WENDY E | Director | 05/08/2012 | 39,747 |
| LANE WENDY E | Director | 05/08/2012 | 69,170 |
| BELINGARD JEAN-LUC | Director | 05/07/2012 | 3,220 |
| BELINGARD JEAN-LUC | Director | 05/01/2012 | 64,971 |
| BELINGARD JEAN-LUC | Director | 05/01/2012 | 119,218 |
| Walton Andrew Scott | EVP | 04/09/2012 | 367,280 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/26/2012 | 764,149 |
| KING DAVID P | President & CEO | 03/26/2012 | 2,544,711 |
| Hayes William B | Chief Financial Officer, EVP | 03/26/2012 | 931,590 |
| Hayes William B | Chief Financial Officer, EVP | 03/26/2012 | 192,913 |
| Hayes William B | Chief Financial Officer, EVP | 03/27/2012 | 1,259,587 |
| Hayes William B | Chief Financial Officer, EVP | 03/26/2012 | 247,500 |
| Walton Andrew Scott | EVP | 03/26/2012 | 459,408 |
| Brecher Mark E | Chief Medical Officer | 03/26/2012 | 147,683 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/26/2012 | 143,272 |
| Fonseca Lidia | Chief Information Officer | 03/26/2012 | 143,272 |
| Hayes William B | Chief Financial Officer, EVP | 03/23/2012 | 4,749,612 |
| Hayes William B | Chief Financial Officer, EVP | 03/23/2012 | 6,866,831 |
| MAC MAHON THOMAS P | Director | 02/29/2012 | 5,398,812 |
| Walton Andrew Scott | EVP | 02/09/2012 | 66,872 |
| Walton Andrew Scott | EVP | 02/10/2012 | 41,954 |
| Hayes William B | Chief Financial Officer, EVP | 02/10/2012 | 79,947 |
| Hayes William B | Chief Financial Officer, EVP | 02/09/2012 | 119,006 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/10/2012 | 41,954 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/09/2012 | 116,795 |
| KING DAVID P | President & CEO | 02/09/2012 | 434,851 |
| KING DAVID P | President & CEO | 02/10/2012 | 285,395 |
| Fonseca Lidia | Chief Information Officer | 02/10/2012 | 15,665 |
| Fonseca Lidia | Chief Information Officer | 02/09/2012 | 27,265 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/10/2012 | 15,665 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/09/2012 | 27,265 |
| Brecher Mark E | Chief Medical Officer | 02/10/2012 | 16,566 |
| Brecher Mark E | Chief Medical Officer | 02/09/2012 | 69,175 |
| KING DAVID P | President & CEO | 01/25/2012 | 1,171,400 |
| KING DAVID P | President & CEO | 01/25/2012 | 1,840,000 |
| KING DAVID P | President & CEO | 12/02/2011 | 957,800 |
| KING DAVID P | President & CEO | 12/02/2011 | 1,760,000 |
| MITTELSTAEDT ROBERT E JR | Director | 08/18/2011 | 64,971 |
| MITTELSTAEDT ROBERT E JR | Director | 08/18/2011 | 65,329 |
| Williams R Sanders | Director | 05/19/2011 | 477,798 |
| Williams R Sanders | Director | 05/19/2011 | 633,769 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 05/13/2011 | 1,196,976 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 05/13/2011 | 1,505,479 |
| BELINGARD JEAN-LUC | Director | 05/12/2011 | 3,000 |
| BELINGARD JEAN-LUC | Director | 05/11/2011 | 64,938 |
| BELINGARD JEAN-LUC | Director | 05/11/2011 | 187,298 |
| BELINGARD JEAN-LUC | Director | 05/09/2011 | 2,954 |
| BELINGARD JEAN-LUC | Director | 05/06/2011 | 3,611 |
| LANE WENDY E | Director | 04/25/2011 | 32,579 |
| LANE WENDY E | Director | 04/25/2011 | 32,469 |
| KING DAVID P | President & CEO | 04/25/2011 | 695,368 |
| Brecher Mark E | Chief Medical Officer | 04/21/2011 | 124,558 |
| MAC MAHON THOMAS P | Director | 04/15/2011 | 6,083,490 |
| MAC MAHON THOMAS P | Director | 04/14/2011 | 4,166,260 |
| MAC MAHON THOMAS P | Director | 04/14/2011 | 6,757,855 |
| MAC MAHON THOMAS P | Director | 04/15/2011 | 8,048,482 |
| Walton Andrew Scott | EVP | 04/14/2011 | 145,825 |
| Walton Andrew Scott | EVP | 04/11/2011 | 142,372 |
| Walton Andrew Scott | EVP | 03/30/2011 | 162,995 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 03/30/2011 | 71,425 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 03/30/2011 | 54,667 |
| Fonseca Lidia | Chief Information Officer | 03/30/2011 | 54,667 |
| KING DAVID P | President & CEO | 03/30/2011 | 979,982 |
| Hayes William B | Chief Financial Officer, EVP | 03/30/2011 | 362,892 |
| Hayes William B | Chief Financial Officer, EVP | 03/31/2011 | 489,866 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/14/2011 | 12,370 |
| Hayes William B | Chief Financial Officer, EVP | 02/14/2011 | 78,255 |
| Hayes William B | Chief Financial Officer, EVP | 02/15/2011 | 105,640 |
| Walton Andrew Scott | EVP | 02/14/2011 | 31,320 |
| KING DAVID P | President & CEO | 02/14/2011 | 213,623 |
| Fonseca Lidia | Chief Information Officer | 02/14/2011 | 12,370 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/14/2011 | 12,370 |
| Hayes William B | Chief Financial Officer, EVP | 02/11/2011 | 160,934 |
| Hayes William B | Chief Financial Officer, EVP | 02/10/2011 | 77,817 |
| Hayes William B | Chief Financial Officer, EVP | 02/09/2011 | 65,151 |
| Hayes William B | Chief Financial Officer, EVP | 02/10/2011 | 1,823,235 |
| Hayes William B | Chief Financial Officer, EVP | 02/10/2011 | 2,805,425 |
| KING DAVID P | President & CEO | 02/10/2011 | 236,169 |
| KING DAVID P | President & CEO | 02/09/2011 | 188,467 |
| Conrad Andrew J | EVP, Chief Scientific Officer | 02/10/2011 | 45,093 |
| Conrad Andrew J | EVP, Chief Scientific Officer | 02/09/2011 | 45,007 |
| Brecher Mark E | Chief Medical Officer | 02/10/2011 | 16,142 |
| Brecher Mark E | Chief Medical Officer | 02/09/2011 | 97,545 |
| Walton Andrew Scott | EVP | 02/09/2011 | 37,385 |
| Walton Andrew Scott | EVP | 02/10/2011 | 40,882 |
| Fonseca Lidia | Chief Information Officer | 02/10/2011 | 15,616 |
| Fonseca Lidia | Chief Information Officer | 02/09/2011 | 15,517 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/09/2011 | 62,157 |
| Boyle James T. Jr. | EVP, Chief Operating Officer | 02/10/2011 | 40,882 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/10/2011 | 15,616 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 02/09/2011 | 15,517 |
| Hayes William B | Chief Financial Officer, EVP | 12/27/2010 | 1,823,175 |
| Hayes William B | Chief Financial Officer, EVP | 12/27/2010 | 2,670,702 |
| MAC MAHON THOMAS P | Director | 12/01/2010 | 8,380,750 |
| MAC MAHON THOMAS P | Director | 12/01/2010 | 13,175,000 |
| Walton Andrew Scott | EVP | 10/29/2010 | 71,361 |
| Walton Andrew Scott | EVP | 10/29/2010 | 71,361 |
| Walton Andrew Scott | EVP | 10/29/2010 | 71,361 |
| Walton Andrew Scott | EVP | 10/29/2010 | 71,361 |
| Hayes William B | Chief Financial Officer, EVP | 10/13/2010 | 1,757,100 |
| Hayes William B | Chief Financial Officer, EVP | 10/13/2010 | 2,400,000 |
| Walton Andrew Scott | EVP | 10/06/2010 | 292,850 |
| Walton Andrew Scott | EVP | 10/06/2010 | 397,500 |
| Walton Andrew Scott | EVP | 10/01/2010 | 69,599 |
| Walton Andrew Scott | EVP | 10/01/2010 | 69,599 |
| MITTELSTAEDT ROBERT E JR | Director | 09/08/2010 |